TempP(2)

TempP(3)

32904593 2020. A Single Large Dose of Vitamin D Could be Used as a Means of Coronavirus Disease 2019 Prevention and Treatment.
32949526 2020. Taming the cytokine storm: repurposing montelukast for the attenuation and prophylaxis of severe COVID-19 symptoms.
32947043 2020. Chloroquine against malaria, cancers and viral diseases.
32997318 2020. Assessing the Safety of COVID-19 Vaccines: A Primer.
32978702 2020. Sex Differences in Reported Adverse Drug Reactions to COVID-19 Drugs in a Global Database of Individual Case Safety Reports.
33014097 2020. Dabigatran, the oral anticoagulant of choice at discharge in patients with non-valvular atrial fibrillation and COVID-19 infection: the ANIBAL protocol.
32952393 2020. Severe prolonged neutropenia following administration of tocilizumab in a patient affected by COVID-19: a case report and brief review of the literature.
32951446 2020. Efficacy of Povidone-Iodine Nasal and Oral Antiseptic Preparations Against Severe Acute Respiratory Syndrome-Coronavirus 2 (SARS-CoV-2).
32950003 2020. Impact of interleukin-6 blockade with tocilizumab on SARS-CoV-2 viral kinetics and antibody responses in patients with COVID-19: A prospective cohort study.
33014130 2020. Possible mechanisms of action of clarithromycin and its clinical application as a repurposing drug for treating multiple myeloma.
32984784 2020. An open-label, randomized trial of the combination of IFN-kappa plus TFF2 with standard care in the treatment of patients with moderate COVID-19.
32837997 2020. Convalescent plasma to treat COVID-19: Its challenges in Iraq's situation.
32933891 2020. Interleukin-6 and severe COVID-19: a systematic review and meta-analysis.
32984253 2020. Importance of Dietary Changes During the Coronavirus Pandemic: How to Upgrade Your Immune Response.
32984235 2020. Ozone Therapy as a Possible Option in COVID-19 Management.
32951474 2020. Potential alteration of COVID-19 by beta-mercaptoethanol.
32974048 2020. Cannabis for COVID-19: can cannabinoids quell the cytokine storm?
32946905 2020. INTESTINAL MICROBIOME MODULATION DURING COVID-19: ANOTHER CHANCE TO MANAGE THE DISEASE?
32920121 2020. SARS-CoV-2 transcriptome analysis and molecular cataloguing of immunodominant epitopes for multi-epitope based vaccine design.
32943258 2020. Vitamin D dosing considerations in COVID-19.
32923351 2020. Cardiometabolic Health: Key in Reducing Adverse COVID-19 Outcomes.
33003439 2020. Evaluation of Country Dietary Habits Using Machine Learning Techniques in Relation to Deaths from COVID-19.
33010945 2020. SGLT-2 inhibitors as cardioprotective agents in COVID-19.
32980171 2020. Anti-inflammatory aspects of Lidocaine: a neglected therapeutic stance for COVID-19.
32911459 2020. Promising impacts of mesenchymal stem cell therapy in treatment of SARS-CoV-2 (COVID-19).
32984620 2020. Nucleic acid-based therapy for coronavirus disease 2019.
32935064 2020. Chloroquine to fight COVID-19: A consideration of mechanisms and adverse effects?
32929412 2020. A systematic review on COVID-19 pandemic with special emphasis on curative potentials of Nigeria based medicinal plants.
32923731 2020. An immunoinformatics study on the spike protein of SARS-CoV-2 revealing potential epitopes as vaccine candidates.
33020742 2020. Novel hybrid antiviral VTRRT-13V2.1 against SARS-CoV2 main protease: retro-combinatorial synthesis and molecular dynamics analysis.
32943233 2020. Endothelial injury and thrombotic microangiopathy in COVID-19: Treatment with the lectin-pathway inhibitor narsoplimab.
33006053 2020. Recent advances, approaches and challenges in targeting pathways for potential COVID-19 vaccines development.
32946016 2020. Molecular mimicry between SARS-CoV-2 spike glycoprotein and mammalian proteomes: implications for the vaccine.
32900263 2020. Cross-neutralization activity against SARS-CoV-2 is present in currently available intravenous immunoglobulins.
32773424 2020. Effect of quantitative real-time RT-PCR reaction sensitivity in determining the efficacy of HCQ prophylaxis for COVID-19.
33012868 2020. Diet, Gut Microbiota and COVID-19.
33013067 2020. Anti-corona Drugs: Current Scenario.
32989938 2020. Convalescent Plasma Therapy for Coronavirus Disease 2019.
32986226 2020. Effect of Corticosteroid Therapy on the Duration of SARS-CoV-2 Clearance in Patients with Mild COVID-19: A Retrospective Cohort Study.
32983830 2020. Factors Associated with Good Patient Outcomes Following Convalescent Plasma in COVID-19: A Prospective Phase II Clinical Trial.
32953385 2020. Steroids and COVID-19: We Need a Precision Approach, Not One Size Fits All.
32943888 2020. Design an Efficient Multi-Epitope Peptide Vaccine Candidate Against SARS-CoV-2: An in silico Analysis.
32920586 2020. Granulocyte colony-stimulating factors (G-CSF) and Covid-19: a double-edged sword?
32920571 2020. The therapeutic potential of convalescent plasma therapy on treating critically-ill COVID-19 patients residing in respiratory care units in hospitals in Baghdad, Iraq.
32921678 2020. Suspected Hydroxychloroquine-Induced Sinus Bradycardia and QTc Prolongation in a Patient with COVID-19.
32919216 2020. Drug repurposing and cytokine management in response to COVID-19: A review.
32896750 2020. Immunomodulatory-based therapy as a potential promising treatment strategy against severe COVID-19 patients: A systematic review.
32987103 2020. Design of novel viral attachment inhibitors of the spike glycoprotein (S) of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) through virtual screening and dynamics.
32991900 2020. Novel insights into the treatment of SARS-CoV-2 infection: An overview of current clinical trials.
32980406 2020. Evaluation of the potency of FDA-approved drugs on wild type and mutant SARS-CoV-2 helicase (Nsp13).
32979436 2020. The structure-activity relationship of the interactions of SARS-CoV-2 spike glycoproteins with glucuronomannan and sulfated galactofucan from Saccharina japonica.
32950529 2020. Prediction of potential inhibitors for RNA-dependent RNA polymerase of SARS-CoV-2 using comprehensive drug repurposing and molecular docking approach.
32956782 2020. Assessing QT interval in COVID-19 patients:safety of hydroxychloroquine-azithromycin combination regimen.
32974857 2020. The therapeutic effects of traditional chinese medicine on COVID-19: a narrative review.
32898838 2020. Nasal disinfection for the prevention and control of COVID-19: A scoping review on potential chemo-preventive agents.
32911042 2020. Analysis of the predictive factors for a critical illness of COVID-19 during treatment relationship between serum zinc level and critical illness of COVID-19.
33007455 2020. COX2 inhibition in the treatment of COVID-19: Review of literature to propose repositioning of celecoxib for randomized controlled studies.
33007454 2020. Early hydroxychloroquine but not chloroquine use reduces ICU admission in COVID-19 patients.
33007453 2020. Use of hydroxychloroquine and chloroquine in COVID-19: How good is the quality of randomized controlled trials?
33002613 2020. Tocilizumab therapy for COVID-19: A comparison of subcutaneous and intravenous therapies.
33002611 2020. Effect of convalescent blood products for patients with severe acute respiratory infections of viral etiology: a systematic review and meta-analysis.
32992014 2020. Favipiravir-induced fever in coronavirus disease 2019: A report of two cases.
32980554 2020. NOD2-dependent BCG-induced trained immunity: A way to regulate innate responses to SARS-CoV2?
32920234 2020. COVID-19: Poor outcomes in patients with zinc deficiency.
33011285 2020. Finding the right time for anti-inflammatory therapy in COVID-19.
33014624 2020. COVID-19 and Child Vaccination: A Systematic Approach to Closing the Immunization Gap.
32922174 2020. COVID-19: Rational discovery of the therapeutic potential of Melatonin as a SARS-CoV-2 main Protease Inhibitor.
32963540 2020. Possible Role for Bacteriophages in the Treatment of SARS-CoV-2 Infection.
33000193 2020. [Comment] COVID19 vaccine safety.
32899381 2020. State of the Art Review of Cell Therapy in the Treatment of Lung Disease, and the Potential for Aerosol Delivery.
32899231 2020. The HMOX1 Pathway as a Promising Target for the Treatment and Prevention of SARS-CoV-2 of 2019 (COVID-19).
33003377 2020. Targeting the SphK-S1P-SIPR Pathway as a Potential Therapeutic Approach for COVID-19.
32957696 2020. Stem Cells Secretome from Oral Tissue Could Represent a Promising Therapeutic Approach in COVID-19-Disease?
32942748 2020. SARS-CoV-2 Infection: A Role for S1P/S1P Receptor Signaling in the Nervous System?
33013255 2020. Screening of FDA Approved Drugs Against SARS-CoV-2 Main Protease: Coronavirus Disease.
32935062 2020. Prospective data linkage to facilitate COVID-19 trials - A call to action.
32939238 2020. Hypothesis of COVID-19 Therapy with Sildenafil.
33011212 2020. Pneumonia After Bacterial or Viral Infection Preceded or Followed by Radiation Exposure: A Reanalysis of Older Radiobiologic Data and Implications for Low Dose Radiation Therapy for Coronavirus Disease 2019 Pneumonia.
32896649 2020. Dexamethasone to combat cytokine storm in COVID-19: Clinical trials and preliminary evidence.
32913393 2020. Possible role of tryptophan and melatonin in COVID-19.
32946004 2020. Hydroxychloroquine and chloroquine retinal safety concerns during COVID-19 outbreak.
32983864 2021. The efficacy and safety of traditional Chinese medicines, modified Radix Fici Simplicissimae, combined with Western medicines amongst patients infected with the 2019 novel coronavirus (SARS-CoV-2) in tropical tourist area, China.
32955678 2020. Systematic review of the prevalence of current smoking among hospitalized COVID-19 patients in China: could nicotine be a therapeutic option? Reply.
33011928 2020. Protective role of statins in COVID 19 patients: importance of pharmacokinetic characteristics rather than intensity of action.
32997237 2020. The association of treatment with hydroxychloroquine and hospital mortality in COVID-19 patients.
32915341 2020. The use of antioxidants against high ferritin-induced oxidation in COVID-19 patients: a biochemical approach.
32964056 2020. Attenuated Subcomponent Vaccine Design Targeting the SARS-CoV-2 Nucleocapsid Phosphoprotein RNA Binding Domain: In Silico Analysis.
32931775 2020. The association between corticosteroid uses and mortality among severe COVID-19 patients.
32988730 2020. Corticosteroids as adjunctive therapy in the treatment of coronavirus disease 2019: A report of two cases and literature review.
32893123 2020. Clinical improvement in a patient with severe coronavirus disease 2019 after administration of hydroxychloroquine and continuous hemodiafiltlation with nafamostat mesylate.
32903227 2020. Can Levamisole be used in the treatment of COVID-19 patients presenting with diarrhea?
32948484 2020. Opinions on the current pandemic of COVID-19: Use functional food to boost our immune functions.
32900666 2020. Positive aspects, negative aspects and limitations of plasma therapy with special reference to COVID-19.
33008778 2020. Association of corticosteroids use and outcomes in COVID-19 patients: A systematic review and meta-analysis.
33008777 2020. In silico molecular docking: Evaluation of coumarin based derivatives against SARS-CoV-2.
32972277 2020. Mesenchymal stem cell research progress for the treatment of COVID-19.
32962495 2020. Possible effect of epinephrine in minimizing COVID-19 severity: a review.
33008774 2020. Dangers of scientific bias against herbal drugs for coronavirus disease 2019.
32980768 2020. Impact of catch-up vaccination on aluminum exposure due to new laws and post social distancing.
32983928 2020. The Application of Corticosteroids in COVID-19: A Two-edged Sword.
32958009 2020. The use of mesenchymal stromal cells in the treatment of coronavirus disease 2019.
32904944 2020. Vitamin D and immune regulation: antibacterial, antiviral, anti-inflammatory.
32984792 2020. Artificial intelligence in COVID-19 drug repurposing.
33015597 2020. Evaluating interest in off-label use of disinfectants for COVID-19.
33024252 2020. Antiviral activity of a novel mixture of natural antimicrobials, in vitro, and in a chicken infection model in vivo.
33017762 2020. Chloroquine commonly induces hormetic dose responses.
32876237 2020. Analisis preliminar in silico de azitromicina con proteinas humanas relacionadas al SARS-CoV-2.
32940187 2020. Tocilizumab in Sars-cov-2 Patients with the Syndrome of Cytokine Storm; a Narrative review.
33020836 2020. Baricitinib improves respiratory function in patients treated with corticosteroids for SARS-CoV-2 pneumonia: an observational cohort study.
32892403 2020. Oromucosal immunomodulation as clinical spectrum mitigating factor in SARS-CoV-2 infection.
32914670 2020. Biomarker-guided application of low-dose anakinra in an acute respiratory distress syndrome patient with severe COVID-19 and cytokine release syndrome.
32907861 2020. De novo design of picomolar SARS-CoV-2 miniprotein inhibitors.

32984783 2020. Towards characterized convalescent plasma for COVID-19: The dose matters.
32923991 2020. Compassionate use of convalescent plasma for treatment of moderate and severe pneumonia in COVID-19 patients and association with IgG antibody levels in donated plasma.
33015938 2020. A comparative analysis of remdesivir and other repurposed antivirals against SARS-CoV-2.
32975484 2020. Targeting the endolysosomal host-SARS-CoV-2 interface by clinically licensed functional inhibitors of acid sphingomyelinase (FIASMA) including the antidepressant fluoxetine.
32897177 2020. SARS-CoV-2 spike produced in insect cells elicits high neutralization titres in non-human primates.
32923016 2020. Efficacy and safety of triazavirin therapy for coronavirus disease 2019: A pilot randomized controlled trial.
32953196 2020. Challenges in the development of a vaccine against COVID-19.
32846177 2020. Biomedical application, drug delivery and metabolic pathway of antiviral nanotherapeutics for combating viral pandemic: A review.
32835682 2020. Do nutrients and other bioactive molecules from foods have anything to say in the treatment against COVID-19?
33003236 2020. Preprocedural Use of Povidone-Iodine Mouthwash during Dental Procedures in the COVID-19 Pandemic.
32968954 2020. Population Pharmacokinetics of Hydroxychloroquine in COVID-19 Patients: Implications for Dose Optimization.
32912961 2020. Observational study on off-label use of tocilizumab in patients with severe COVID-19.
32981802 2020. COVID-19 randomized controlled trials in medRxiv and PubMed.
33010419 2020. Therapeutic Strategies for SARS-CoV-2 acting on ACE-2.
32941927 2020. Corticosteroid therapy is associated with the delay of SARS-CoV-2 clearance in COVID-19 patients.
33011243 2020. New putative insights into neprilysin (NEP)-dependent pharmacotherapeutic role of roflumilast in treating COVID-19.
32931782 2020. Possibility of magnesium supplementation for supportive treatment in patients with COVID-19.
32926918 2020. COVID-19 associated complications and potential therapeutic targets.
32971089 2020. Integrative transcriptomics analysis of lung epithelial cells and identification of repurposable drug candidates for COVID-19.
32949606 2020. Antiviral activity of chlorpromazine, fluphenazine, perphenazine, prochlorperazine, and thioridazine towards RNA-viruses. A review.
32946870 2020. Can pentoxifylline and similar xanthine derivatives find a niche in COVID-19 therapeutic strategies? A ray of hope in the midst of the pandemic.
32919938 2020. Macrophage responses associated with COVID-19: A pharmacological perspective.
32943404 2020. Intravenous methylprednisolone pulse as a treatment for hospitalised severe COVID-19 patients: results from a randomised controlled clinical trial.
32983273 2020. Why physical activity matters for older adults in a time of pandemic.
32963564 2020. Tea Polyphenols EGCG and Theaflavin Inhibit the Activity of SARS-CoV-2 3CL-Protease In Vitro.
32963563 2020. Efficacy of Lianhua Qingwen Compared with Conventional Drugs in the Treatment of Common Pneumonia and COVID-19 Pneumonia: A Meta-Analysis.
32901214 2020. Frontiers in the COVID-19 vaccines development.
32934806 2020. Prediction of repurposed drugs for treating lung injury in COVID-19.
32971210 2020. Comprehensive assessment of side effects in COVID-19 drug pipeline from a network perspective.
32860861 2020. Synergistic effects of anionic surfactants on coronavirus (SARS-CoV-2) virucidal efficiency of sanitizing fluids to fight COVID-19.
32822775 2020. Tocilizumab improves oxidative stress and endothelial glycocalyx: A mechanism that may explain the effects of biological treatment on COVID-19.
32838301 2020. Employing bioactive compounds derived from Ipomoea obscura (L.) to evaluate potential inhibitor for SARS-CoV-2 main protease and ACE2 protein.
32846611 2020. Potential contribution of beneficial microbes to face the COVID-19 pandemic.
33011274 2020. Control of systemic inflammation through early nitric oxide supplementation with nitric oxide releasing nanoparticles.
32974328 2020. Low-Cost, Large-Scale Production of the Anti-viral Lectin Griffithsin.
32974295 2020. Potential Applications of Nanomaterials to Quench the Cytokine Storm in Coronavirus Disease 19.
32850752 2020. Prospects for RNAi Therapy of COVID-19.
32984339 2020. Repurposing Fragile X Drugs to Inhibit SARS-CoV-2 Viral Reproduction.
33013911 2020. Scientific Rationale for a Bottom-Up Approach to Target the Host Response in Order to Try and Reduce the Numbers Presenting With Adult Respiratory Distress Syndrome Associated With COVID-19. Is There a Role for Statins and COX-2 Inhibitors in the Prevention and Early Treatment of the Disease?
33013871 2020. Mitigating Coronavirus Induced Dysfunctional Immunity for At-Risk Populations in COVID-19: Trained Immunity, BCG and "New Old Friends".
33013857 2020. Identification of Novel Candidate Epitopes on SARS-CoV-2 Proteins for South America: A Review of HLA Frequencies by Country.
32983183 2020. What Would Jenner and Pasteur Have Done About COVID-19 Coronavirus? The Urges of a Vaccinologist.
32983179 2020. Immune Modulation as a Therapeutic Option During the SARS-CoV-2 Outbreak: The Case for Antimalarial Aminoquinolines.
32983123 2020. Case Report: Canakinumab for the Treatment of a Patient With COVID-19 Acute Respiratory Distress Syndrome.
32973818 2020. PI3Kdelta Inhibition as a Potential Therapeutic Target in COVID-19.
32973815 2020. Hyperinflammation and Fibrosis in Severe COVID-19 Patients: Galectin-3, a Target Molecule to Consider.
32973814 2020. Immunomodulatory and Antiviral Activity of Metformin and Its Potential Implications in Treating Coronavirus Disease 2019 and Lung Injury.
32973779 2020. The 2020 Pandemic: Current SARS-CoV-2 Vaccine Development.
32922409 2020. Treatment of COVID-19 With Conestat Alfa, a Regulator of the Complement, Contact Activation and Kallikrein-Kinin System.
32922408 2020. Vaccine Development Against COVID-19 Prior to Pandemic Outbreaks, Using in vitro Evolution and Reverse Genetics.
32903555 2020. Immunomodulatory Drugs in the Management of SARS-CoV-2.
32926320 2020. Chinese herbal medicine reduces mortality in patients with severe and critical Coronavirus disease 2019: a retrospective cohort study.
32926319 2020. Clinical features and the traditional Chinese medicine therapeutic characteristics of 293 COVID-19 inpatient cases.
32903552 2020. A Simple Bayesian Method for Evaluating Whether Data From Patients With Rheumatic Diseases Who Have Been Under Chronic Hydroxychloroquine Medication Since Before the COVID-19 Outbreak Can Speak to Hydroxychloroquine's Prophylactic Effect Against Infection With SARS-CoV-2.
32982999 2020. Severity of Coronavirus Disease 2019 (COVID-19): Does Surfactant Matter?
32903349 2020. Antivirals Against Coronaviruses: Candidate Drugs for SARS-CoV-2 Treatment?
33015130 2020. Selenium and RNA Virus Interactions: Potential Implications for SARS-CoV-2 Infection (COVID-19).
32984400 2020. Understanding Selenium and Glutathione as Antiviral Factors in COVID-19: Does the Viral M(pro) Protease Target Host Selenoproteins and Glutathione Synthesis?
33014780 2020. Tyrosine Kinase Inhibitors Play an Antiviral Action in Patients Affected by Chronic Myeloid Leukemia: A Possible Model Supporting Their Use in the Fight Against SARS-CoV-2.
32974166 2020. Commentary: SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor.
32923397 2020. Management of Patients With Hematologic Malignancies During the COVID-19 Pandemic: Practical Considerations and Lessons to Be Learned.
33013421 2020. Inhibiting Extracellular Vesicle Trafficking as Antiviral Approach to Corona Virus Disease 2019 Infection.
33013412 2020. Efficacy and Safety of Corticosteroid Treatment in Patients With COVID-19: A Systematic Review and Meta-Analysis.
33013397 2020. Clinical Studies on the Treatment of Novel Coronavirus Pneumonia With Traditional Chinese Medicine-A Literature Analysis.
33013395 2020. Research Progress on Main Symptoms of Novel Coronavirus Pneumonia Improved by Traditional Chinese Medicine.
33013375 2020. Montelukast Drug May Improve COVID-19 Prognosis: A Review of Evidence.
32982751 2020. Coronavirus Disease 2019 Related Clinical Studies: A Cross-Sectional Analysis.
32982743 2020. Immunosuppressive Drugs and COVID-19: A Review.
32982720 2020. SARS-CoV-2 Treatment Approaches: Numerous Options, No Certainty for a Versatile Virus.
32973537 2020. Does Lithium Deserve a Place in the Treatment Against COVID-19? A Preliminary Observational Study in Six Patients, Case Report.
32973535 2020. Quality Assessment of the Chinese Clinical Trial Protocols Regarding Treatments for Coronavirus Disease 2019.
32973527 2020. Harnessing Memory NK Cell to Protect Against COVID-19.
33015643 2020. Anti-C5a antibody IFX-1 (vilobelimab) treatment versus best supportive care for patients with severe COVID-19 (PANAMO): an exploratory, open-label, phase 2 randomised controlled trial.
33015642 2020. The opening salvo of anti-complement therapy against COVID-19.
32964210 2020. Tocilizumab in COVID-19: finding the optimal route and dose - Authors' reply.
32964209 2020. Tocilizumab in COVID-19: finding the optimal route and dose.
32929415 2020. COVACTA trial raises questions about tocilizumab's benefit in COVID-19.
33024086 2020. Is smaller better? Vaccine targeting recombinant receptor-binding domain might hold the key for mass production of effective prophylactics to fight the COVID-19 pandemic.
33024082 2020. The efficacy assessment of convalescent plasma therapy for COVID-19 patients: a multi-center case series.
33024075 2020. Salvianolic acid C potently inhibits SARS-CoV-2 infection by blocking the formation of six-helix bundle core of spike protein.
33024071 2020. SARS-CoV-2: the many pros of targeting PLpro.
32989778 2020. Provision of COVID-19 Convalescent Plasma in a Resource-Constrained State.
32978802 2020. Characterization of 100 sequential SARS-CoV-2 convalescent plasma donations.
32989856 2020. Treatment of Immunocompromised COVID-19 patients with Convalescent Plasma.
32980540 2020. Claims about the safety and efficacy of early treatment of COVID-19 with hydroxychloroquine and azithromycin must be supported by real evidence.
32956851 2020. Dangers of the use of hydroxychloroquine and azithromycin combination in COVID-19 patients.
32916297 2020. Antimalarial drugs inhibit the replication of SARS-CoV-2: An in vitro evaluation.
32891724 2020. Histamine release theory and roles of antihistamine in the treatment of cytokines storm of COVID-19.
33023856 2020. The Complement C5a-C5aR1 GPCR Axis in COVID-19 Therapeutics.
32959455 2020. Pregnancy and COVID-19: Pharmacologic Considerations.
32996648 2020. Pregnancies recovered from SARS-CoV-2 infection in second or third trimester: obstetric evolution.
32990149 2020. Correlation analysis of coagulation dysfunction and liver damage in patients with novel coronavirus pneumonia: a single-center, retrospective, observational study.
33012602 2020. Ensemble forecast modeling for the design of COVID-19 vaccine efficacy trials.
33022950 2020. Cold-Adapted Live Attenuated SARS-Cov-2 Vaccine Completely Protects Human ACE2 Transgenic Mice from SARS-Cov-2 Infection.
33022917 2020. Influences on Attitudes Regarding Potential COVID-19 Vaccination in the United States.
32933365 2020. Optimization of hydroxychloroquine dosing scheme based on COVID-19 patients' characteristics: a review of the literature and simulations.
32792464 2020. Knowledge transfer for large-scale vaccine manufacturing.
32942923 2020. A Review of the Preclinical and Clinical Efficacy of Remdesivir, Hydroxychloroquine, and Lopinavir-Ritonavir Treatments against COVID-19.
32940386 2020. Therapeutic plasma exchange therapy support for critical COVID-19: A case report.
32926660 2020. Review of Current Vaccine Development Strategies to Prevent Coronavirus Disease 2019 (COVID-19).
32919880 2020. A consideration of convalescent plasma and plasma derivatives in the care of Severely-ill patients with COVID-19.
32994125 2020. Convalescent plasma to aid in recovery of COVID-19 pneumonia in a child with acute lymphoblastic leukemia.
32935877 2020. Screening for SARS-CoV-2 antibodies in convalescent plasma in Brazil: Preliminary lessons from a voluntary convalescent donor program.
32935872 2020. SARS-CoV-2 neutralization and serology testing of COVID-19 convalescent plasma from donors with nonsevere disease.
32896672 2020. Can influenza vaccine modify COVID-19 clinical course?
33012020 2020. COVID-19 vaccine research and development: ethical issues.
32926494 2020. Maternal and Perinatal Outcomes of Pregnant Women with SARS-COV-2 infection.
32980199 2020. Intention of nurses to accept coronavirus disease 2019 vaccination and change of intention to accept seasonal influenza vaccination during the coronavirus disease 2019 pandemic: A cross-sectional survey.
32985963 2020. Coronavirus Disease 2019 Vaccine Development: An Overview.
33012270 2020. Letter to the Editor: Toll-Like Receptor Antagonists as a Potential Therapeutic Strategy Against Cytokine Storm in COVID-19-Infected Patients.
32914674 2020. Can intravenous oxytocin infusion counteract hyperinflammation in COVID-19 infected patients?
32893565 2020. [Investigation of modulating effect of Qingfei Paidu Decoction on host metabolism and gut microbiome in rats].

32973505 2020. Repurposing Drugs, Ongoing Vaccine, and New Therapeutic Development Initiatives Against COVID-19.
32973504 2020. The C-C Chemokine Receptor Type 4 Is an Immunomodulatory Target of Hydroxychloroquine.
32903363 2020. Corticosteroid Use in the Treatment of COVID-19: A Multicenter Retrospective Study in Hunan, China.
33013486 2020. A Preventive Role of Exercise Across the Coronavirus 2 (SARS-CoV-2) Pandemic.
32983220 2020. Pandemics and Traditional Plant-Based Remedies. A Historical-Botanical Review in the Era of COVID19.
32922431 2020. COVID-19 Therapy: Could a Chlorophyll Derivative Promote Cellular Accumulation of Zn(2+) Ions to Inhibit SARS-CoV-2 RNA Synthesis?
33014983 2020. A Basic Review of the Preliminary Evidence That COVID-19 Risk and Severity Is Increased in Vitamin D Deficiency.
32967965 2020. Template-dependent inhibition of coronavirus RNA-dependent RNA polymerase by remdesivir reveals a second mechanism of action.
32999432 2020. Imatinib is not a potent anti-SARS-CoV-2 drug.
32979360 2020. Mesenchymal stem cell therapies for COVID-19: Current status and mechanism of action.
32956664 2020. Assessment of effective imidazole derivatives against SARS-CoV-2 main protease through computational approach.
32926920 2020. New insights on possible vaccine development against SARS-CoV-2.
32952690 2020. Possible Nutritional Interventions in COVID 19.
32978312 2020. Antiviral Drug Discovery To Address the COVID-19 Pandemic.
32963010 2020. Reply to Ozdemir, "Measles-Mumps-Rubella Vaccine and COVID-19 Relationship".
32963005 2020. Measles-Mumps-Rubella Vaccine and COVID-19 Relationship.
32929317 2020. What are the drugs having potential against COVID-19?
32959021 2020. Expanded mesenchymal stem cells: a novel therapeutic approach for SARS-CoV-2 pneumonia (COVID-19). Concepts regarding a first case in Spain.
32953990 2020. Potential drug-drug interactions in COVID 19 patients in treatment with lopinavir/ritonavir.
32964205 2020. Serum Levels of Vitamin C and Vitamin D in a Cohort of Critically Ill COVID-19 Patients of a North American Community Hospital Intensive Care Unit in May 2020: A Pilot Study.
33004713 2020. COVID-19 deaths can be reduced - simply and safely!
33004712 2020. Rationale for ozone-therapy as an adjuvant therapy in COVID-19: a narrative review.
32895599 2020. Favipiravir: A new and emerging antiviral option in COVID-19.
33010355 2020. Jaundice in a patient treated with Anakinra in a context of Covid-19.
32898996 2020. Convalescent plasma therapy in critically ill coronavirus disease 2019 patients with persistently positive nucleic acid test, case series report.
32976855 2020. Commentary: Statins, COVID-19, and coronary artery disease: killing two birds with one stone.
32950636 2020. Use of Nasoil(R) via intranasal to control the harmful effects of Covid-19.
33011363 2020. Novel cyclohexanone compound as a potential ligand against SARS-CoV-2 main-protease.
32899776 2020. Evaluation of Antiviral, Antibacterial and Antiproliferative Activities of the Endophytic Fungus Curvularia papendorfii, and Isolation of a New Polyhydroxyacid.
32998451 2020. Renin Angiotensin System, COVID-19 and Male Fertility: Any Risk for Conceiving?
32962760 2020. Successful recovery of COVID-19-associated recurrent diarrhea and gastrointestinal hemorrhage using convalescent plasma.
33000616 2020. Can estrogens protect against COVID-19? The COVID-19 puzzling and gender medicine.
32921819 2020. The Challenges of Vaccine Development against Betacoronaviruses: Antibody Dependent Enhancement and Sendai Virus as a Possible Vaccine Vector.
32920757 2020. Role of melatonin in the treatment of COVID-19; as an adjuvant through cluster differentiation 147 (CD147).
32997257 2020. A multimodal deep learning-based drug repurposing approach for treatment of COVID-19.
32996011 2020. Identification of potential inhibitors of coronavirus hemagglutinin-esterase using molecular docking, molecular dynamics simulation and binding free energy calculation.
32926254 2020. Synthesis of 3,3'-methylenebis(4-hydroxyquinolin-2(1H)-ones) of prospective anti-COVID-19 drugs.
32993479 2020. Nebulized in-line endotracheal dornase alfa and albuterol administered to mechanically ventilated COVID-19 patients: a case series.
32897518 2020. Effects of Antimalarial Drugs on Neuroinflammation-Potential Use for Treatment of COVID-19-Related Neurologic Complications.
32906733 2020. The New Coronavirus (SARS-CoV-2): A Comprehensive Review on Immunity and the Application of Bioinformatics and Molecular Modeling to the Discovery of Potential Anti-SARS-CoV-2 Agents.
32992875 2020. Targeting Host Defense System and Rescuing Compromised Mitochondria to Increase Tolerance against Pathogens by Melatonin May Impact Outcome of Deadly Virus Infection Pertinent to COVID-19.
32987757 2020. Peptides: Prospects for Use in the Treatment of COVID-19.
32977525 2020. The Application of Porphyrins and Their Analogues for Inactivation of Viruses.
32963099 2020. In Silico Structure-Based Repositioning of Approved Drugs for Spike Glycoprotein S2 Domain Fusion Peptide of SARS-CoV-2: Rationale from Molecular Dynamics and Binding Free Energy Calculations.
32877576 2020. Phase 1-2 Trial of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine.
32895172 2020. [A systematic pharmacological investigation of pharmacologically active ingredients in Toujie Quwen granules for treatment of COVID-19].
32963581 2020. Antiviral nanoagents: More attention and effort needed?
32952596 2020. Nanoceria as a possible agent for the management of COVID-19.
32922510 2020. Multivalent nanomedicines to treat COVID-19: A slow train coming.
32904707 2020. Nanomedicine strategies to target coronavirus.
32989315 2020. Whither COVID-19 vaccines?
32887884 2020. Both Boceprevir and GC376 efficaciously inhibit SARS-CoV-2 by targeting its main protease.
32887876 2020. An alpaca nanobody neutralizes SARS-CoV-2 by blocking receptor interaction.
32943628 2020. Rapid incorporation of Favipiravir by the fast and permissive viral RNA polymerase complex results in SARS-CoV-2 lethal mutagenesis.
32913273 2020. Humanized single domain antibodies neutralize SARS-CoV-2 by targeting the spike receptor binding domain.
32855413 2020. Feline coronavirus drug inhibits the main protease of SARS-CoV-2 and blocks virus replication.
32887954 2020. Immunological considerations for COVID-19 vaccine strategies.
32989290 2020. Keeping track of the SARS-CoV-2 vaccine pipeline.
32901129 2020. Haemoperfusion should only be used for COVID-19 in the context of randomized trials.
32892293 2020. Hydroxychloroquine use and progression or prognosis of COVID-19: a systematic review and meta-analysis.
33001407 2020. Locking down the CGRP pathway during the COVID-19 pandemic lockdown: the PandeMig study.
32922804 2020. Preliminary report of in vitro and in vivo effectiveness of dornase alfa on SARS-CoV-2 infection.
32895614 2020. Statins-based prophylactic mouthwash and nasal spray may protect against coronavirus disease 2019.
32960622 2020. Interaccion entre la edad y el deficit de vitamina D en la COVID-19 grave.
32911778 2020. Current State of Evidence: Influence of Nutritional and Nutrigenetic Factors on Immunity in the COVID-19 Pandemic Framework.
33003648 2020. Effective Immune Functions of Micronutrients against SARS-CoV-2.
32963672 2020. Expedited COVID-19 vaccine trials: a rat-race with challenges and ethical issues.
32911671 2020. Control Measures for SARS-CoV-2: A Review on Light-Based Inactivation of Single-Stranded RNA Viruses.
32999768 2020. Potential COVID-19 papain-like protease PL(pro) inhibitors: repurposing FDA-approved drugs.
32998368 2020. Papain-Like Proteases as Coronaviral Drug Targets: Current Inhibitors, Opportunities, and Limitations.
32977547 2020. Potential of Cell-Free Supernatant from Lactobacillus plantarum NIBR97, Including Novel Bacteriocins, as a Natural Alternative to Chemical Disinfectants.
32967280 2020. Molecular Features of Non-Selective Small Molecule Antagonists of the Bradykinin Receptors.
33007416 2020. Natural product derived phytochemicals in managing acute lung injury by multiple mechanisms.
32930523 2020. Pharmacological hypothesis: TPC2 antagonist tetrandrine as a potential therapeutic agent for COVID-19.
32910933 2020. Chloroquine and hydroxychloroquine in the treatment of malaria and repurposing in treating COVID-19.
33011728 2020. SARS-CoV-2 and the Possible Role of Raf/MEK/ERK Pathway in Viral Survival: Is This a Potential Therapeutic Strategy for COVID-19?
32994757 2020. Possible pharmaceutical applications can be developed from naturally occurring phenanthroindolizidine and phenanthroquinolizidine alkaloids.
32982616 2020. Flavonoids: A complementary approach to conventional therapy of COVID-19?
32978039 2020. Systems pharmacological study illustrates the immune regulation, anti-infection, anti-inflammation, and multi-organ protection mechanism of Qing-Fei-Pai-Du decoction in the treatment of COVID-19.
32943302 2020. Identification of phytochemicals as potential therapeutic agents that binds to Nsp15 protein target of coronavirus (SARS-CoV-2) that are capable of inhibiting virus replication.
32949888 2020. Network pharmacology analysis of the therapeutic mechanisms of the traditional Chinese herbal formula Lian Hua Qing Wen in Corona virus disease 2019 (COVID-19), gives fundamental support to the clinical use of LHQW.
32920291 2020. Chloroquine and hydroxychloroquine as ACE2 blockers to inhibit viropexis of 2019-nCoV Spike pseudotyped virus.
32948420 2020. Caffeic acid derivatives (CAFDs) as inhibitors of SARS-CoV-2: CAFDs-based functional foods as a potential alternative approach to combat COVID-19.
32967179 2020. Plants-Derived Biomolecules as Potent Antiviral Phytomedicines: New Insights on Ethnobotanical Evidences against Coronaviruses.
32941437 2020. Interventions for treatment of COVID-19: A living systematic review with meta-analyses and trial sequential analyses (The LIVING Project).
33022015 2020. Biochemical screening for SARS-CoV-2 main protease inhibitors.
33007039 2020. Brief Report: Hydroxychloroquine does not induce hemolytic anemia or organ damage in a "humanized" G6PD A- mouse model.
33006999 2020. In-silico drug repurposing study predicts the combination of pirfenidone and melatonin as a promising candidate therapy to reduce SARS-CoV-2 infection progression and respiratory distress caused by cytokine storm.
33002032 2020. In-silico design of a potential inhibitor of SARS-CoV-2 S protein.
32976513 2020. Vitamin D sufficiency, a serum 25-hydroxyvitamin D at least 30 ng/mL reduced risk for adverse clinical outcomes in patients with COVID-19 infection.
32960899 2020. Second week methyl-prednisolone pulses improve prognosis in patients with severe coronavirus disease 2019 pneumonia: An observational comparative study using routine care data.
32941512 2020. SARS-CoV-2 positivity rates associated with circulating 25-hydroxyvitamin D levels.
32915877 2020. Traditional Chinese medicine Lianhua Qingwen treating corona virus disease 2019(COVID-19): Meta-analysis of randomized controlled trials.
32915876 2020. A new advanced in silico drug discovery method for novel coronavirus (SARS-CoV-2) with tensor decomposition-based unsupervised feature extraction.
32913357 2020. Competing with a pandemic: Trends in research design in a time of Covid-19.
32903258 2020. Efficacy of corticosteroids in non-intensive care unit patients with COVID-19 pneumonia from the New York Metropolitan region.
32983403 2020. Hydroxychloroquine and chloroquine for COVID-19: psychiatric aspects of patient safety considerations.
33014364 2020. Convalescent Blood Products in COVID-19: A Narrative Review.
32952617 2020. Oral disease-modifying antirheumatic drugs and immunosuppressants with antiviral potential, including SARS-CoV-2 infection: a review.
32974002 2020. Clozapine prescribing in COVID-19 positive medical inpatients: a case series.
32922212 2020. Thrombotic events following tocilizumab therapy in critically ill COVID-19 patients: a Facade for prognostic markers.
32900176 2020. Pasient med alvorlig covid-19 behandlet med rekonvalesensplasma.
32900168 2020. Pasient med alvorlig covid-19 behandlet med steroider.
32998488 2020. Status for vaksineutvikling mot covid-19.
32920000 2020. Safety assessment of drug combinations used in COVID-19 treatment: in silico toxicogenomic data-mining approach.
32957454 2020. Novel Binding Mechanisms of Fusion Broad Range Anti-Infective Protein Ricin A Chain Mutant-Pokeweed Antiviral Protein 1 (RTAM-PAP1) against SARS-CoV-2 Key Proteins in Silico.
32972861 2020. Promoting access to COVID-19 convalescent plasma in low- and middle-income countries.
33011076 2020. Convalescent plasma therapy in patients with COVID-19.
32933845 2020. Response Letter: Treatment for emerging viruses: Convalescent plasma and COVID-19.
32900597 2020. Convalescent plasma as a treatment modality for coronavirus disease 2019 in Sudan.
32669327 2020. A Novel Mucosal Adjuvant System for Immunization against Avian Coronavirus Causing Infectious Bronchitis.
32913137 2020. Heparin-binding Peptides as Novel Therapies to Stop SARS-CoV-2 Cellular Entry and Infection.

32963442 2020. Past, Present, and Future of Remdesivir: An Overview of the Antiviral in Recent Times.
32922463 2020. Thalidomide against Coronavirus Disease 2019 (COVID-19): A Medicine with a Thousand Faces.
32947026 2020. Three patients with X-linked agammaglobulinemia hospitalized for COVID-19 improved with convalescent plasma.
32962355 2020. Assessment of proton-coupled conformational dynamics of SARS and MERS coronavirus papain-like proteases: Implication for designing broad-spectrum antiviral inhibitors.
32920346 2020. Preanesthetic Povidone-Iodine gargles for patients with COVID-19.
32910806 2020. Convalescent plasma anti-SARS-CoV-2 spike protein ectodomain and receptor binding domain IgG correlate with virus neutralization.
32976118 2020. Corticosteroids, COVID-19 pneumonia, and acute respiratory distress syndrome.
32931482 2020. Drugs of unproven benefit for COVID-19: a pharma perspective on ethical allocation of available therapies.
32967358 2020. Can Adenosine Fight COVID-19 Acute Respiratory Distress Syndrome?
32937800 2020. Colchicine to Weather the Cytokine Storm in Hospitalized Patients with COVID-19.
32933039 2020. The Efficacy of the Mineralcorticoid Receptor Antagonist Canrenone in COVID-19 Patients.
32932930 2020. Repurposing Immunomodulatory Therapies against Coronavirus Disease 2019 (COVID-19) in the Era of Cardiac Vigilance: A Systematic Review.
32900588 2020. Anti-inflammatory properties of antidiabetic drugs: A "promised land" in the COVID-19 era?
32905026 2020. Pharmaceutical assessment of polyvinylpyrrolidone (PVP): As excipient from conventional to controlled delivery systems with a spotlight on COVID-19 inhibition.
32989715 2020. Expert Forecasts of COVID-19 Vaccine Development Timelines.
32943741 2020. Promising effects of exercise on the cardiovascular, metabolic and immune system during COVID-19 period.
32921965 2020. Biological, molecular and pharmacological characteristics of chloroquine, hydroxychloroquine, convalescent plasma, and remdesivir for COVID-19 pandemic: A comparative analysis.
32920049 2020. Anti-Frameshifting Ligand Active against SARS Coronavirus-2 Is Resistant to Natural Mutations of the Frameshift-Stimulatory Pseudoknot.
32891636 2020. MicroRNAs targeting the SARS-CoV-2 entry receptor ACE2 in cardiomyocytes.
32952595 2020. Ramatroban as a Novel Immunotherapy for COVID-19.
33007575 2020. An in-silico evaluation of COVID-19 main protease with clinically approved drugs.
32920239 2020. Targeting the SARS-CoV-2 main protease using FDA-approved Isavuconazonium, a P2-P3 alpha-ketoamide derivative and Pentagastrin: An in-silico drug discovery approach.
32965508 2020. Insights into the biased activity of dextromethorphan and haloperidol towards SARS-CoV-2 NSP6: in silico binding mechanistic analysis.
32904625 2021. Exploration of inhibitory action of Azo imidazole derivatives against COVID-19 main protease (M(pro)): A computational study.
32963413 2021. Synthesis, characterization and computational study on potential inhibitory action of novel azo imidazole derivatives against COVID-19 main protease (M(pro): 6LU7).
32997331 2020. Treatment of COVID-19 atypical pneumonia by early Tocilizumab administration in "non-critically-ill" patients on hemodialysis.
32996110 2020. COVID-19 and acute kidney injury in pediatric subjects: is there a place for eculizumab treatment?
32981025 2020. Eculizumab treatment for renal failure in a pediatric patient with COVID-19.
32908681 2020. Possible Retinal Impairment Secondary to Ritonavir Use in SARS-CoV-2 Patients: A Narrative Systematic Review.
32944152 2020. Antiviral mouthwashes: possible benefit for COVID-19 with evidence-based approach.
32744616 2020. Vaccination Against Severe Acute Respiratory Syndrome Coronavirus 2.
32992693 2020. Pharmaconutrition in the Clinical Management of COVID-19: A Lack of Evidence-Based Research But Clues to Personalized Prescription.
32923004 2020. Potential Treatment of Chinese and Western Medicine Targeting Nsp14 of SARS-CoV-2.
32968487 2020. The use of remdesivir outside of clinical trials during the COVID-19 pandemic.
32891630 2020. Development of a Minimal Physiologically-Based Pharmacokinetic Model to Simulate Lung Exposure in Humans Following Oral Administration of Ivermectin for COVID-19 Drug Repurposing.
32840378 2020. Alkamides and Piperamides as Potential Antivirals against the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2).
32952005 2020. Coronavirus Disease 2019: Quick Diet and Nutrition Guide for Patients With Chronic Kidney Disease.
32992538 2020. Nutritional Risk Screening Tools for Older Adults with COVID-19: A Systematic Review.
32967126 2020. Immune Modulatory Effects of Vitamin D on Viral Infections.
32932831 2020. Impact of Vitamin D Deficiency on COVID-19-A Prospective Analysis from the CovILD Registry.
32927735 2020. Vitamin D Deficiency and Outcome of COVID-19 Patients.
32942131 2020. Induction of ketosis as a potential therapeutic option to limit hyperglycemia and prevent cytokine storm in COVID-19.
32911430 2020. Vitamin C as prophylaxis and adjunctive medical treatment for COVID-19?
32917467 2020. Nutritional approach to patients with coronavirus: Our experience in a 914 COVID-19-bed hospital.
32991984 2020. SARS-CoV-2 receptor ACE2 is expressed in human conjunctival tissue, especially in diseased conjunctival tissue.
32923151 2020. Combination treatments with hydroxychloroquine and azithromycin are compatible with the therapeutic induction of anticancer immune responses.
32898468 2020. Convalescent plasma therapy: a promising coronavirus disease 2019 treatment strategy.
32934969 2020. Remdesivir Treatment for Severe COVID-19 in Third-Trimester Pregnancy: Case Report and Management Discussion.
32938758 2020. Relationships between hyperinsulinaemia, magnesium, vitamin D, thrombosis and COVID-19: rationale for clinical management.
32895293 2020. Ivermectin may be a clinically useful anti-inflammatory agent for late-stage COVID-19.
32901226 2020. Vitamin D and COVID-19: Is something better than nothing?
33014275 2020. COVID-19: Proposing a Ketone-Based Metabolic Therapy as a Treatment to Blunt the Cytokine Storm.
32855764 2020. Natural Antioxidants: A Review of Studies on Human and Animal Coronavirus.
32942797 2020. Overview of Stem Cell Therapy for Acute Respiratory Distress Syndrome with Focus on COVID 19.
32942796 2020. Safety and Effectiveness of Intravascular Mesenchymal Stem Cells to Treat Organ Failure and Possible Application in COVID-19 Complications.
32942793 2020. COVID-19 Pandemic - A Narrative Review of the Potential Roles of Chloroquine and Hydroxychloroquine.
32997719 2020. Translational Research in the Time of COVID-19-Dissolving Boundaries.
32946517 2020. Exploring links between vitamin D deficiency and COVID-19.
33013180 2021. Topical review on nano-vaccinology: Biochemical promises and key challenges.
32977289 2020. Leukotrienes, a potential target for Covid-19.
33005274 2020. Effective treatment of severe acute pancreatitis and COVID-19 pneumonia with tocilizumab.
32956989 2020. Serum 25-hydroxyvitamin D levels and psychological distress symptoms in patients with affective disorders during the COVID-19 pandemic.
32901209 2020. Radiological and clinical improvement in a patient with COVID-19 pneumonia postconvalescent plasma transfusion: A case report.
33007504 2020. Mitigation of the replication of SARS-CoV-2 by nitric oxide in vitro.
32992282 2020. Selenium and selenoproteins in viral infection with potential relevance to COVID-19.
32972871 2020. Clinical study of novel coronavirus pneumonia prevention by melatonin.
32962929 2020. Melatonin: a fertility-friendly anti-coronavirus agent.
32982538 2020. Off-Label Use of Chloroquine and Hydroxychloroquine for COVID-19 Treatment in Africa Against WHO Recommendation.
32893160 2020. Outcome of early-stage combination treatment with favipiravir and methylprednisolone for severe COVID-19 pneumonia: A report of 11 cases.
32995261 2020. Methylprednisolone pulse therapy: An alternative management of severe COVID-19.
32965370 2020. Safety alert for hospital environments and health professional: chlorhexidine is ineffective for coronavirus.
32965359 2020. The effects of favipiravir on hematological parameters of covid-19 patients.
32965395 2020. Justificativa e delineamento do estudo "Tocilizumabe em pacientes com COVID-19 moderado a grave: estudo aberto, multicentrico, randomizado, controlado" (TOCIBRAS).
32921873 2020. Utilidad y seguridad de la automonitorizacion electrocardiografica durante el tratamiento con hidroxicloroquina y azitromicina en pacientes con COVID-19.
32963418 2020. Recomendacion de ejercicio fisico en casa en periodo de pandemia por COVID-19.
32900514 2020. Uso de ozonoterapia rectal en paciente anciana con neumonia grave por COVID-19.
32935536 2020. Inmunidad frente a SARS-CoV-2: caminando hacia la vacunacion.
32965457 2020. Early public research funding response to COVID-19 pandemic in Brazil.
32964179 2020. Safety of intravenous anakinra in COVID-19 with evidence of hyperinflammation, a case series.
32904919 2020. Mesenchymal Stem Cell Therapy-Is the Vessel Half Full or Half Empty?
32904846 2020. Knowledge about COVID-19 and beliefs about and use of herbal products during the COVID-19 pandemic: a cross-sectional study in Saudi Arabia.
33020690 2020. Comparing the impact of Hydroxychloroquine based regimens and standard treatment on COVID-19 patient outcomes: A retrospective cohort study.
32917717 2020. Molecular characterization of ebselen binding activity to SARS-CoV-2 main protease.
32948512 2020. Antibody-like proteins that capture and neutralize SARS-CoV-2.
32937442 2020. COVID-19: Rescue by transcriptional inhibition.
32923629 2020. Viruses harness YxxO motif to interact with host AP2M1 for replication: A vulnerable broad-spectrum antiviral target.
32923613 2020. Mandated Bacillus Calmette-Guerin (BCG) vaccination predicts flattened curves for the spread of COVID-19.
32938937 2020. Structural models of human ACE2 variants with SARS-CoV-2 Spike protein for structure-based drug design.
32973171 2020. Sequence analysis of SARS-CoV-2 genome reveals features important for vaccine design.
33004978 2020. Designing a multi-epitope peptide based vaccine against SARS-CoV-2.
33004837 2020. Antiviral activity of digoxin and ouabain against SARS-CoV-2 infection and its implication for COVID-19.
32963884 2020. Computer-Aided Analysis of Multiple SARS-CoV-2 Therapeutic Targets: Identification of Potent Molecules from African Medicinal Plants.
32963228 2020. Receptor-binding domain-specific human neutralizing monoclonal antibodies against SARS-CoV and SARS-CoV-2.
32934211 2020. Convalescent plasma therapy for COVID-19: a tried-and-true old strategy?
33011739 2020. A cell-based large-scale screening of natural compounds for inhibitors of SARS-CoV-2.
32981460 2020. Discovery of Drug-Like Ligands for the Mac1 Domain of SARS-CoV-2 Nsp3.
33015537 2020. Elderly as a High-risk Group during COVID-19 Pandemic: Effect of Circadian Misalignment, Sleep Dysregulation and Melatonin Administration.
32954212 2020. Cytokine Hemoadsorption in the Management of a Pregnant Woman with COVID-19 Pneumonia: Case Report.
32935079 2020. Role of Dupilumab in Approved Indications of COVID-19 Patient: an Efficacy-Based Nonsystematic Critical Analysis.
32904710 2020. A Review on Current Repurposing Drugs for the Treatment of COVID-19: Reality and Challenges.
32864572 2020. Treatment Options Available for COVID-19 and an Analysis on Possible Role of Combination of rhACE2, Angiotensin (1-7) and Angiotensin (1-9) as Effective Therapeutic Measure.
32950067 2020. Human Mesenchymal Stromal Cells Are Resistant to SARS-CoV-2 Infection under Steady-State, Inflammatory Conditions and in the Presence of SARS-CoV-2-Infected Cells.
32948252 2020. The role of mesenchymal stromal cells in immune modulation of COVID-19: focus on cytokine storm.
32895900 2020. Mesenchymal Stromal Cells in Viral Infections: Implications for COVID-19.
32920752 2020. COVID-19 and its Therapeutics: Special Emphasis on Mesenchymal Stem Cells Based Therapy.
33009982 2020. Cell-Based Therapy for Severe COVID-19 Patients: Clinical Trials and Cost-Utility.
33014070 2020. The Potential Use of Mesenchymal Stem Cells and Their Derived Exosomes as Immunomodulatory Agents for COVID-19 Patients.
32961040 2020. Viral pandemic preparedness: A pluripotent stem cell-based machine-learning platform for simulating SARS-CoV-2 infection to enable drug discovery and repurposing.
32907757 2020. Amplifying immunogenicity of prospective Covid-19 vaccines by glycoengineering the coronavirus glycan-shield to present alpha-gal epitopes.
33010978 2020. Enhanced elicitation of potent neutralizing antibodies by the SARS-CoV-2 spike receptor binding domain Fc fusion protein in mice.
32907759 2020. The Brighton Collaboration standardized template for collection of key information for benefit-risk assessment of viral vector vaccines.
32987794 2020. Possible Cross-Reactivity between SARS-CoV-2 Proteins, CRM197 and Proteins in Pneumococcal Vaccines May Protect Against Symptomatic SARS-CoV-2 Disease and Death.

33015628 2020. Computational Evaluation of the Inhibition Efficacies of HIV Antivirals on SARS-CoV-2 (COVID-19) Protease and Identification of 3D Pharmacophore and Hit Compounds.
32982145 2020. COVID-19: the androgen hypothesis.
32991573 2020. A 63-Year-Old Woman with SARS-CoV-2 Infection, Who Developed Severe COVID-19 Pneumonia and Was Supported with Convalescent Plasma Therapy.
33009361 2020. A 63-Year-Old Woman with a History of Non-Hodgkin Lymphoma with Persistent SARS-CoV-2 Infection Who Was Seronegative and Treated with Convalescent Plasma.
32955087 2020. Creation and maintenance of a table for assessment of evolving evidence for COVID-19-related treatments.
33001237 2020. FX06-COVID: Verbesserung der Oxygenierung durch FX06 in Intensivpatienten mit schweren Verlaufen von COVID-19.
32990812 2020. Vitamins as adjunctive treatment for coronavirus disease!
32976026 2020. Convalescent Plasma for the Treatment of COVID-19: Perspectives of the National Institutes of Health COVID-19 Treatment Guidelines Panel.
33017175 2020. Should Remdesivir Be Used for the Treatment of Patients With COVID-19? Rapid, Living Practice Points From the American College of Physicians (Version 1).
33017170 2020. Remdesivir for Adults With COVID-19 : A Living Systematic Review for an American College of Physicians Practice Points.
33012516 2020. Sevoflurane may not be a complete sigh of relief in COVID-19.
32959913 2020. A PHARMACOLOGICAL FRAMEWORK FOR INTEGRATING TREATING THE HOST, REPURPOSING AND THE DAMAGE RESPONSE FRAMEWORK IN COVID-19.
32936703 2020. Nutritional management of patients during and after COVID-19 illness.
32988425 2020. Invited Letter to Editor in response to: Finland's handling of selenium is a model in these times of coronavirus infections.
32988420 2020. Finland's handling of selenium is a model in these times of coronavirus infections.
32942296 2020. Potential inhibitors for the novel coronavirus (SARS-CoV-2).
33003194 2020. Adverse events associated with potential drugs for COVID-19: a case study from real-world data.
32985700 2020. Mining the past to treat the present, ever mindful of the future: Low-dose radiotherapy and COVID-19 pneumonia.
32945149 2020. Convalescent Plasma for the Treatment of Severe COVID-19 Infection in Cancer Patients.
32905553 2020. Towards COVID-19 Prophylaxis: An AIDS Preclinical Research Perspective.
32923657 2020. Cannabidiol Modulates Cytokine Storm in Acute Respiratory Distress Syndrome Induced by Simulated Viral Infection Using Synthetic RNA.
32918656 2020. Lopinavir-Ritonavir in SARS-CoV-2 Infection and Drug-Drug Interactions with Cardioactive Medications.
32795413 2020. A Thermostable mRNA Vaccine against COVID-19.
32970990 2020. Structurally Resolved SARS-CoV-2 Antibody Shows High Efficacy in Severely Infected Hamsters and Provides a Potent Cocktail Pairing Strategy.
32941803 2020. High Potency of a Bivalent Human VH Domain in SARS-CoV-2 Animal Models.
32941801 2020. Activate: Randomized Clinical Trial of BCG Vaccination against Infection in the Elderly.
32931734 2020. A Single-Dose Intranasal ChAd Vaccine Protects Upper and Lower Respiratory Tracts against SARS-CoV-2.
32992409 2020. SARS-COV-2 (COVID-19): Cellular and biochemical properties and pharmacological insights into new therapeutic developments.
32803762 2020. Potential small-molecule drugs as available weapons to fight novel coronavirus (2019-nCoV): A review.
32814759 2020. On-target versus off-target effects of drugs inhibiting the replication of SARS-CoV-2.
32934821 2020. Decreased HD-MIR2911 absorption in human subjects with the SIDT1 polymorphism fails to inhibit SARS-CoV-2 replication.
32901211 2020. Immunization with the receptor-binding domain of SARS-CoV-2 elicits antibodies cross-neutralizing SARS-CoV-2 and SARS-CoV without antibody-dependent enhancement.
32802404 2020. Absorbed plant MIR2911 in honeysuckle decoction inhibits SARS-CoV-2 replication and accelerates the negative conversion of infected patients.
32910920 2020. Neutralization of SARS-CoV-2 by Destruction of the Prefusion Spike.
32910919 2020. Snatching the Crown from SARS-CoV-2.
32798445 2020. Replication-Competent Vesicular Stomatitis Virus Vaccine Vector Protects against SARS-CoV-2-Mediated Pathogenesis in Mice.
32798444 2020. Approaches and Challenges in SARS-CoV-2 Vaccine Development.
32941797 2020. Shining Light on the COVID-19 Pandemic: A Vitamin D Receptor Checkpoint in Defense of Unregulated Wound Healing.
32868909 2020. New insights into the cell- and tissue-specificity of glucocorticoid actions.
32830930 2020. Emergence, Transmission, and Potential Therapeutic Targets for the COVID-19 Pandemic Associated with the SARS-CoV-2.
33007239 2020. Furin Inhibitors Block SARS-CoV-2 Spike Protein Cleavage to Suppress Virus Production and Cytopathic Effects.
32984856 2020. Programming Multifaceted Pulmonary T Cell Immunity by Combination Adjuvants.
32811977 2020. 25-Hydroxycholesterol is a potent SARS-CoV-2 inhibitor.
32841042 2020. The Disillusioned Comfort with COVID-19 and the Potential of Convalescent Plasma and Cell Therapy.
32830527 2020. Immunomodulation and Regeneration Properties of Dental Pulp Stem Cells: A Potential Therapy to Treat Coronavirus Disease 2019.
32899484 2020. Hybrid Biopolymer and Lipid Nanoparticles with Improved Transfection Efficacy for mRNA.
32887260 2020. Rationale for the Use of Radiation-Activated Mesenchymal Stromal/Stem Cells in Acute Respiratory Distress Syndrome.
32942671 2020. Ivermectin as a Broad-Spectrum Host-Directed Antiviral: The Real Deal?
32854430 2020. Targeting the sAC-Dependent cAMP Pool to Prevent SARS-Cov-2 Infection.
32847034 2020. Autophagy Augmentation to Alleviate Immune Response Dysfunction, and Resolve Respiratory and COVID-19 Exacerbations.
32796683 2020. Small Molecule Inhibitors in the Treatment of Rheumatoid Arthritis and Beyond: Latest Updates and Potential Strategy for Fighting COVID-19.
32834643 2020. Target specific mining of COVID-19 scholarly articles using one-class approach.
31436895 2019. Characteristics of flavonoids as potent MERS-CoV 3C-like protease inhibitors.
32836314 2020. Favipiravir - a Modern Antiviral Drug: Synthesis and Modifications.
32834063 2020. Quantum mechanical simulation of Chloroquine drug interaction with C60 fullerene for treatment of COVID-19.
32835090 2020. In Silico Identification of Potential Inhibitors of ADP-Ribose Phosphatase of SARS-CoV-2 nsP3 by Combining E-Pharmacophore- and Receptor-Based Virtual Screening of Database.
32929323 2020. Rudolf Bauer: China anti-COVID-19 success is closely related with the role TCM played.
32994803 2020. Applications, phytochemistry, pharmacological effects, pharmacokinetics, toxicity of Scutellaria baicalensis Georgi. and its probably potential therapeutic effects on COVID-19: a review.
32905189 2020. Reflections on treatment of COVID-19 with traditional Chinese medicine.
32863397 2020. Stability Indicating LC Method Development for Hydroxychloroquine Sulfate Impurities as Available for Treatment of COVID-19 and Evaluation of Risk Assessment Prior to Method Validation by Quality by Design Approach.
32876256 2020. Terapia medicamentosa para infeccoes por coronavirus em humanos: revisao sistematica rapida.
32830894 2020. Canakinumab to reduce deterioration of cardiac and respiratory function in SARS-CoV-2 associated myocardial injury with heightened inflammation (canakinumab in Covid-19 cardiac injury: The three C study).
32941626 2020. No SARS-CoV-2 Neutralization by Intravenous Immunoglobulins Produced From Plasma Collected Before the 2020 Pandemic.
32990950 2020. Vitamin D status may indeed be a prognosticator for morbidity and mortality in patients with COVID-19.
32975843 2020. Inactivation of SARS-CoV-2 and HCoV-229E in vitro by ColdZyme(R) a medical device mouth spray against the common cold.
32965715 2020. Convalescent plasma for the treatment of patients with severe coronavirus disease 2019: A preliminary report.
32965677 2020. N-terminally truncated nucleocapsid protein of SARS-CoV-2 as a better serological marker than whole nucleocapsid protein in evaluating the immunogenicity of inactivated SARS-CoV-2.
32949157 2020. Safety of nontumor necrosis factor-targeted biologics in the COVID-19 pandemic.
33022569 2020. Prediction of potential inhibitors of the dimeric SARS-CoV2 main proteinase through the MM/GBSA approach.
33006287 2020. A Novel Strategy for the Development of Vaccines for SARS-CoV-2 (COVID-19) and Other Viruses Using AI and Viral Shell Disorder.
32960061 2020. Theoretical Insights into the Anti-SARS-CoV-2 Activity of Chloroquine and Its Analogs and In Silico Screening of Main Protease Inhibitors.
32957788 2020. Techniques and Strategies for Potential Protein Target Discovery and Active Pharmaceutical Molecule Screening in a Pandemic.
32931291 2020. Generation of SARS-CoV-2 S1 Spike Glycoprotein Putative Antigenic Epitopes in Vitro by Intracellular Aminopeptidases.
32914632 2020. Computational Immune Proteomics Approach to Target COVID-19.
32907334 2020. Repurposing of FDA-Approved Toremifene to Treat COVID-19 by Blocking the Spike Glycoprotein and NSP14 of SARS-CoV-2.
32893632 2020. In Silico Drug Repurposing for SARS-CoV-2 Main Proteinase and Spike Proteins.
32786890 2020. Interaction of Drug Candidates with Various SARS-CoV-2 Receptors: An in Silico Study to Combat COVID-19.
32891161 2020. How to deal with a temporary suspension and restarting your trial: our experiences and lessons learnt.
32993804 2020. Moving fast but going slow: coordination challenges for trials of COVID-19 post-exposure prophylaxis.
32928313 2020. A quadruple blind, randomised controlled trial of gargling agents in reducing intraoral viral load among hospitalised COVID-19 patients: A structured summary of a study protocol for a randomised controlled trial.
32917258 2020. It is unprecedented: trial management during the COVID-19 pandemic and beyond.
32988811 2020. Convalescent Plasma Rescued a Severe COVID-19 Patient with Chronic Myeloid Leukemia Blast Crisis and Myelofibrosis.
32950044 2020. Efficacy of convalescent plasma according to blood groups in COVID-19 patients.
32918809 2020. Paul G. Harch, MD: Hyperbaric Oxygen Therapy and Coronavirus Application.
32918807 2020. Vitamin D: A Nutrient To Bring To Light During COVID-19.
32907358 2020. Traditional Chinese Medicine as Potential Therapy for COVID-19.
33017527 2020. Use of povidone as a mouthrinse to decrease the viral load of Covid-19 before dental care: Review of the literature.
32918336 2020. Janus Family kinase (JAK) inhibitors in HLH and severe COVID-19.
32929975 2020. Safety and Utility of Chloroquine/ Hydroxychloroquine in Palliative Care Patients.
32560964 2020. Facts, not Fear: Safety of Hydroxychloroquine.
32964535 2020. Cardiovascular adverse events associated with hydroxychloroquine and chloroquine: A comprehensive pharmacovigilance analysis of pre-COVID-19 reports.
32921328 2020. Probiotics and COVID-19: Think about the link.
32990020 2020. Flavonoids as a potential adjuvant therapy of COVID-19?
32990019 2020. Could boron be used as coronavirus inactivation agent?
32955901 2020. How do arbidol and its analogs inhibit the SARS-CoV-2?
32986274 2020. Low-dose whole-lung radiation for COVID-19 pneumonia: Planned day 7 interim analysis of a registered clinical trial.
32948613 2020. Repurposing Cancer Drugs for COVID-19.
32941264 2020. The Use of Non-Steroidal Anti-inflammatory Drugs for Coronavirus Disease 2019: Adjunct Therapy.
33017365 2020. Use of Nonsteroidal Anti-inflammatory Drugs for COVID-19 Infection: Adjunct Therapy?
32990980 2020. The possible double-edged sword effects of vitamin D on COVID-19: A hypothesis.
32997483 2020. Use of chloroquine or hydroxychloroquine in treatment of COVID-19: is it ethical?
32984999 2020. Virtual screening for functional foods against the main protease of SARS-CoV-2.
32930657 2020. Zinc sulfate in combination with a zinc ionophore may improve outcomes in hospitalized COVID-19 patients.
32897543 2020. Analysis of the prophylactic effect of thymosin drugs on COVID-19 for 435 medical staff: A hospital-based retrospective study.
32897539 2020. Potential role of subcutaneous tocilizumab injections in patients with COVID-19 associated pneumonia.
32940918 2020. Potential interventions for SARS-CoV-2 infections: Zinc showing promise.
32936465 2020. Research progress and challenges to coronavirus vaccine development.
32926453 2020. Methotrexate inhibits SARS-CoV-2 virus replication "in vitro".
32918755 2020. Efficacy of tocilizumab in COVID-19: A systematic review and meta-analysis.
33026649 2020. Suppression of SARS-CoV-2 infection in ex-vivo human lung tissues by targeting class III phosphoinositide 3-kinase.
32794723 2020. Biological Rationale for the Repurposing of BCG Vaccine against SARS-CoV-2.
32786685 2020. Molecular Binding Mechanism and Pharmacology Comparative Analysis of Noscapine for Repurposing against SARS-CoV-2 Protease.

32944838 2020. Pulmonary administration of remdesivir in the treatment of COVID-19.
32966040 2020. Targeting Polyamines Inhibits Coronavirus Infection by Reducing Cellular Attachment and Entry.
32968208 2020. Pharmacological and cardiovascular perspectives on the treatment of COVID-19 with chloroquine derivatives.
33005428 2020. Late i.v. steroid treatment for severe COVID-19-induced acute respiratory distress syndrome: a case report.
32975565 2020. Coronavirus Disease 2019 (COVID-19) and Nutritional Status: The Missing Link?
32955676 2020. Vitamin D status and COVID-19 in older adults.
33014532 2020. Research progress on Mesenchymal Stem Cells (MSCs), Adipose-Derived Mesenchymal Stem Cells (AD-MSCs), Drugs, and Vaccines in Inhibiting COVID-19 Disease.
33014531 2020. Stem Cell Based Therapy Option in COVID-19: Is It Really Promising?
32905393 2020. Structural basis of SARS-CoV-2 main protease inhibition by a broad-spectrum anti-coronaviral drug.
32991850 2020. Statin Treatment of COVID-19.
32891399 2020. Meta-analysis of Effect of Statins in Patients with COVID-19.
32835721 2020. Hydroxychloroquine at usual doses as an option for coronavirus disease 2019 treatment.
32996774 2020. VITAMIN D SUPPLEMENTATION AS A RATIONAL PHARMACOLOGICAL APPROACH IN THE COVID-19 PANDEMIC.
32897730 2020. Complement Inhibition with the C5 Blocker LFG316 in Severe COVID-19.
32804682 2020. Vitamin D Supplementation in COVID-19 Patients: A Clinical Case Series.
32946668 2020. Tocilizumab for severe COVID-19 in solid organ transplant recipients: a matched cohort study.
32828137 2020. Accelerating Clinical Evaluation of Repurposed Combination Therapies for COVID-19.
32828135 2020. Hydroxychloroquine in the Treatment of COVID-19: A Multicenter Randomized Controlled Study.
32895612 2020. An overview of current COVID-19 clinical trials and ethical considerations editorial.
32959507 2020. Association between trace levels of lithium in drinking water and COVID-19-associated mortality.
33012858 2020. Melanie Saville: the end-to-end process needed for a SARS-CoV-2 vaccine.
33017034 2020. Integrative Medicine Demonstrates Advantage in COVID-19 Treatment.
33017033 2020. A Potential Chinese Medicine Granule Suppressing ARDS of COVID-19: Keguan-1.
32974949 2020. Shedding light on the myths of ultraviolet radiation in the COVID-19 pandemic.
32976637 2020. Covid-19: From structure to therapeutic targeting in studying approved drugs and local DNA vaccination.
32986807 2020. Remdesivir failure with SARS-CoV-2 RNA-dependent RNA-polymerase mutation in a B-cell immunodeficient patient with protracted Covid-19.
32964918 2020. Double-blind, randomized, placebo-controlled trial with N-acetylcysteine for treatment of severe acute respiratory syndrome caused by COVID-19.
32964913 2020. Decreased mortality in COVID-19 patients treated with Tocilizumab: a rapid systematic review and meta-analysis of observational studies.
32955081 2020. Treatment of COVID-19 Patients with Prolonged Post-Symptomatic Viral Shedding with Leflunomide -- a Single-Center, Randomized, Controlled Clinical Trial.
32948881 2020. Corticosteroid-related in-hospital hyperglycemia: does it negate mortality benefits in COVID-19?
32934054 2020. Vitamin D binding protein in COVID-19.
32907512 2020. SARS-CoV M(pro) inhibitory activity of aromatic disulfide compounds: QSAR model.
32897178 2020. Molecular docking, validation, dynamics simulations, and pharmacokinetic prediction of natural compounds against the SARS-CoV-2 main-protease.
32897173 2020. Drug similarity and structure-based screening of medicinal compounds to target macrodomain-I from SARS-CoV-2 to rescue the host immune system: a molecular dynamics study.
32897138 2020. Screening of plant-based natural compounds as a potential COVID-19 main protease inhibitor: an in silico docking and molecular dynamics simulation approach.
32896226 2020. In-silico screening of plant-derived antivirals against main protease, 3CL(pro) and endoribonuclease, NSP15 proteins of SARS-CoV-2.
32981461 2020. Pharmacophore based virtual screening, molecular docking, molecular dynamics and MM-GBSA approach for identification of prospective SARS-CoV-2 inhibitor from natural product databases.
32969333 2020. Repurposing of the approved small molecule drugs in order to inhibit SARS-CoV-2 S protein and human ACE2 interaction through virtual screening approaches.
32964805 2020. Repurposing drugs for treatment of SARS-CoV-2 infection: computational design insights into mechanisms of action.
32964802 2020. Identification of destabilizing SNPs in SARS-CoV2-ACE2 protein and spike glycoprotein: implications for virus entry mechanisms.
32960159 2020. The potential role of procyanidin as a therapeutic agent against SARS-CoV-2: a text mining, molecular docking and molecular dynamics simulation approach.
32954984 2020. In silico modeling for quick prediction of inhibitory activity against 3CL(pro) enzyme in SARS CoV diseases.
32948116 2020. Identification of potential inhibitors of SARS-CoV-2 main protease and spike receptor from 10 important spices through structure-based virtual screening and molecular dynamic study.
32948103 2020. A computational approach to drug repurposing against SARS-CoV-2 RNA dependent RNA polymerase (RdRp).
32940134 2020. A dynamic simulation study of FDA drug from zinc database against COVID-19 main protease receptor.
32938313 2020. In silico investigation of spice molecules as potent inhibitor of SARS-CoV-2.
32936048 2020. Molecular basis of the potential interaction of SARS-CoV-2 spike protein to CD147 in COVID-19 associated-lymphopenia.
32933378 2020. Targeting SARS-CoV-2 Nsp12/Nsp8 interaction interface with approved and investigational drugs: an in silico structure-based approach.
32930058 2020. Naltrexone a potential therapeutic candidate for COVID-19.
32930050 2020. Binding of raloxifene to human complement fragment 5a ((h)C5a): a perspective on cytokine storm and COVID19.
32924827 2020. Potential protease inhibitors and their combinations to block SARS-CoV-2.
32924825 2020. Computational insight of dexamethasone against potential targets of SARS-CoV-2.
32909528 2020. Virtual screening of approved clinic drugs with main protease (3CL(pro)) reveals potential inhibitory effects on SARS-CoV-2.
33016237 2020. Structural analysis, virtual screening and molecular simulation to identify potential inhibitors targeting 2'-O-ribose methyltransferase of SARS-CoV-2 coronavirus.
32959892 2020. Quantitative proteomics reveals a broad-spectrum antiviral property of ivermectin, benefiting for COVID-19 treatment.
32981089 2020. Chloroquine and hydroxychloroquine for COVID-19: Perspectives on their failure in repurposing.
32998618 2020. The inhibitory effect of some natural bioactive compounds against SARS-CoV-2 main protease: insights from molecular docking analysis and molecular dynamic simulation.
32977363 2020. Anti-androgens may protect against severe COVID-19 outcomes: results from a prospective cohort study of 77 hospitalized men.
32907596 2020. In vitro virucidal activity of Echinaforce(R), an Echinacea purpurea preparation, against coronaviruses, including common cold coronavirus 229E and SARS-CoV-2.
32972430 2020. Favipiravir versus other antiviral or standard of care for COVID-19 treatment: a rapid systematic review and meta-analysis.
32997322 2020. COVID-19: Antiviral Agents, Antibody Development and Traditional Chinese Medicine.
32910347 2020. Comparative Antiviral Efficacy of Viral Protease Inhibitors against the Novel SARS-CoV-2 In Vitro.
32987033 2020. Transcription-based drug repurposing for COVID-19.
32979476 2020. Current approaches for target-specific drug discovery using natural compounds against SARS-CoV-2 infection.
32899480 2020. Attenuated Influenza Virions Expressing the SARS-CoV-2 Receptor-Binding Domain Induce Neutralizing Antibodies in Mice.
32993173 2020. Potential Anti-SARS-CoV-2 Therapeutics That Target the Post-Entry Stages of the Viral Life Cycle: A Comprehensive Review.
32993136 2020. Network Controllability-Based Prioritization of Candidates for SARS-CoV-2 Drug Repositioning.
32972027 2020. Drug Repositioning: New Approaches and Future Prospects for Life-Debilitating Diseases and the COVID-19 Pandemic Outbreak.
32953852 2020. Clinical efficacy of tocilizumab treatment in severe and critical COVID-19 patients.
32952855 2020. Mesenchymal stromal cells as potential immunomodulatory players in severe acute respiratory distress syndrome induced by SARS-CoV-2 infection.
32952854 2020. Off-the-shelf mesenchymal stem cells from human umbilical cord tissue can significantly improve symptoms in COVID-19 patients: An analysis of evidential relations.
32882767 2020. Use of Darunavir-Cobicistat as a Treatment Option for Critically Ill Patients with SARS-CoV-2 Infection.
32921732 2020. Therapeutic strategies against COVID-19.
32921741 2020. Treatments for COVID-19: emerging drugs against the coronavirus - reply.
32921740 2020. Treatments for COVID-19: emerging drugs against the coronavirus.
32986604 2020. Herd immunization with childhood vaccination may provide protection against COVID-19.
32985199 2020. Immunotherapy Approaches on Innate Immunity for SARS-Cov2.
32985211 2020. Potential therapeutic effects of Resveratrol against SARS-CoV-2.
32924219 2020. An Antioxidant Enzyme Therapeutic for COVID-19.
32894782 2020. Thirty-six COVID-19 cases preventively vaccinated with mumps-measles-rubella vaccine: All mild course.
32955921 2020. Is Interleukin 6 the Right Target in COVID-19 Severe Pneumonia?
32926809 2020. Immunomodulators in COVID-19: Two Sides to Every Coin.
33021529 2020. Tocilizumab-Associated Bowel Perforation in SARS-CoV-2 Infection.
32683974 2020. Gastrointestinal Perforation After Treatment With Tocilizumab : An Unexpected Consequence of COVID-19 Pandemic.
33015631 2020. The successful use of extracorporeal carbon dioxide removal as a rescue therapy in a patient with severe COVID-19 pneumonitis.
32939952 2020. Targeting RNA G-Quadruplex in SARS-CoV-2: A Promising Therapeutic Target for COVID-19?
32212920 2020. Ethics of Conducting Clinical Research in an Outbreak Setting.
33001206 2020. Waning of SARS-CoV-2 RBD antibodies in longitudinal convalescent plasma samples within four months after symptom onset.
32959052 2020. Convalescent plasma therapy for B-cell-depleted patients with protracted COVID-19.
32909956 2020. Covid-19: Pharma companies promise not to bow to political pressure to rush vaccine production.
32907856 2020. Covid-19: Oxford researchers halt vaccine trial while adverse reaction is investigated.
32895223 2020. We need better evidence on non-drug interventions for covid-19.
32972969 2020. Covid-19: FDA plans strict vaccine approval criteria, angering Trump.
32938632 2020. Covid 19: Science must come first with vaccine, says former CDC chief.
32933945 2020. Convalescent plasma for covid-19.
32933902 2020. Covid-19: RECOVERY trial will evaluate "antiviral antibody cocktail".
32917676 2020. Update to living systematic review on drug treatments for covid-19.
33020072 2020. Covid-19: how to prioritize worse-off populations in allocating safe and effective vaccines.
33004419 2020. Covid-19: Anti-TNF drug adalimumab to be trialled for patients in the community.
33004346 2020. Covid-19: Vaccine roll out could take a year and will require difficult prioritisation decisions.
32915473 2020. Gold Metallodrugs to Target Coronavirus Proteins: Inhibitory Effects on the Spike-ACE2 Interaction and on PLpro Protease Activity by Auranofin and Gold Organometallics.
32930481 2020. Structure-Activity Relationships of Benzamides and Isoindolines Designed as SARS-CoV Protease Inhibitors Effective against SARS-CoV-2.
32907357 2020. Electrocardiographic QT Intervals in Infants Exposed to Hydroxychloroquine Throughout Gestation.
32970974 2020. Exosomes: Applications in Respiratory Infectious Diseases and Prospects for Coronavirus Disease 2019 (COVID-19).
32914690 2020. Synthesis of exfoliated multilayer graphene and its putative interactions with SARS-CoV-2 virus investigated through computational studies.
32909925 2020. Exploring structural dynamics of the MERS-CoV receptor DPP4 and mutant DPP4 receptors.
33023417 2020. In silico exploration of small-molecule alpha-helix mimetics as inhibitors of SARS-COV-2 attachment to ACE2.
32901936 2020. Targeted therapy strategies against SARS-CoV-2 cell entry mechanisms: A systematic review of in vitro and in vivo studies.
32914973 2020. What Are the Odds of Finding a COVID-19 Drug from a Lab Repurposing Screen?
32947506 2020. Systematic Review and Meta-analysis of the Effectiveness and Safety of Hydroxychloroquine in Treating COVID-19 Patients.
32909898 2020. The Role of Phosphodiesterase-5 Inhibitors in COVID-19: An Exploration of Literature From Similar Pathologies.
32960147 2020. Therapeutic Effectiveness of Interferon-alpha2b Against COVID-19: The Cuban Experience.

32961123 2020. Hydroxychloroquine early in pregnancy and risk of birth defects.
32771381 2020. Use of remdesivir for pregnant patients with severe novel coronavirus disease 2019.
32915649 2020. Potential mechanism underlying the effect of matrine on COVID-19 patients revealed through network pharmacological approaches and molecular docking analysis.
32959495 2020. Anakinra for COVID-19: how to interpret elevations in serum liver enzymes.
32951346 2020. Reply - "Anakinra for COVID-19: how to interpret elevations in liver enzymes".
32921881 2020. Immunosuppression for COVID-19: repurposing medicines in a pandemic.
33014319 2020. Nanoformulation-Based Antiviral Combination Therapy for Treatment of COVID-19.
33014317 2020. Effective Anti-SARS-CoV-2 RNA Dependent RNA Polymerase Drugs Based on Docking Methods: The Case of Milbemycin, Ivermectin, and Baloxavir Marboxil.
32952745 2020. How menaquinone-7 deficiency influences mortality and morbidity among COVID-19 patients.
32958250 2020. Potent antiviral effect of silver nanoparticles on SARS-CoV-2.
32977949 2020. Andrographolide and its fluorescent derivative inhibit the main proteases of 2019-nCoV and SARS-CoV through covalent linkage.
32905794 2020. The inorganic polymer, polyphosphate, blocks binding of SARS-CoV-2 spike protein to ACE2 receptor at physiological concentrations.
32966814 2020. AR12 (OSU-03012) suppresses GRP78 expression and inhibits SARS-CoV-2 replication.
32956643 2020. Role of proteolytic enzymes in the COVID-19 infection and promising therapeutic approaches.
32891697 2020. Treatments in Covid-19 patients with pre-existing metabolic dysfunction-associated fatty liver disease: A potential threat for drug-induced liver injury?
32920170 2020. May omega-3 fatty acid dietary supplementation help reduce severe complications in Covid-19 patients?
32983259 2020. Therapeutic mechanism of Toujie Quwen granules in COVID-19 based on network pharmacology.
32983936 2020. Effect of bromhexine on clinical outcomes and mortality in COVID-19 patients: A randomized clinical trial.
32901413 2020. A Review on the Serum Electrolytes and Trace Elements Role in the Pathophysiology of COVID-19.
32921981 2020. A Review on Novel Drug Targets and Future Directions for COVID-19 Treatment.
32962156 2020. A Putative Prophylactic Solution for COVID-19: Development of Novel Multiepitope Vaccine Candidate against SARS-COV-2 by Comprehensive Immunoinformatic and Molecular Modelling Approach.
33012699 2020. Valinomycin as a potential antiviral agent against coronaviruses: A review.
32942152 2020. Candesartan could ameliorate the COVID-19 cytokine storm.
32920514 2020. The role of Interleukin 6 inhibitors in therapy of severe COVID-19.
32920511 2020. Can a metabolism-targeted therapeutic intervention successfully subjugate SARS-COV-2? A scientific rational.
33015160 2020. Effects of Short-Term Low-Dose Glucocorticoids for Patients with Mild COVID-19.
32987828 2020. The Impacts of Antivirals on the Coronavirus Genome Structure and Subsequent Pathogenicity, Virus Fitness and Antiviral Design.
32978962 2020. Improving precision and power in randomized trials for COVID-19 treatments using covariate adjustment, for binary, ordinal, and time-to-event outcomes.
32967116 2020. Recognition of Potential COVID-19 Drug Treatments through the Study of Existing Protein-Drug and Protein-Protein Structures: An Analysis of Kinetically Active Residues.
32947136 2020. Druggable targets of SARS-CoV-2 and treatment opportunities for COVID-19.
33007742 2020. Role of heterocyclic compounds in SARS and SARS CoV-2 pandemic.
32927129 2020. Is oseltamivir suitable for fighting against COVID-19: In silico assessment, in vitro and retrospective study.
32992245 2020. COVID-19 therapy: What weapons do we bring into battle?
32916377 2020. Silico analysis of interaction between full-length SARS-CoV2 S protein with human Ace2 receptor: Modelling, docking, MD simulation.
33022567 2020. 1,2,4 triazolo[1,5-a] pyrimidin-7-ones as novel SARS-CoV-2 Main protease inhibitors: In silico screening and molecular dynamics simulation of potential COVID-19 drug candidates.
32941783 2020. The Inhibitory Effect of a Coronavirus Spike Protein Fragment with ACE2.
32761223 2020. Earlier the better: convalescent plasma.
32915971 2020. COVID-19 convalescent plasma clears SARS-CoV-2 refractory to remdesivir in an infant with congenital heart disease.
32958120 2020. Cardiotoxicity induced by the combination therapy of chloroquine and azithromycin in human embryonic stem cell-derived cardiomyocytes.
32993622 2020. Repurposing existing drugs for COVID-19: an endocrinology perspective.
33008327 2020. Subcutaneous injection of IFN alpha-2b for COVID-19: an observational study.
32900372 2020. Treatment estimands in clinical trials of patients hospitalised for COVID-19: ensuring trials ask the right questions.
32958495 2020. Protocol for the DisCoVeRy trial: multicentre, adaptive, randomised trial of the safety and efficacy of treatments for COVID-19 in hospitalised adults.
32928868 2020. Currently prescribed drugs in the UK that could upregulate or downregulate ACE2 in COVID-19 disease: a systematic review.
32913008 2020. Vimentin as a target for the treatment of COVID-19.
32981567 2020. Pre-exposure prophylaxis during the SARS-CoV-2 pandemic: can PrEP prevent COVID-19-related symptoms?
32949135 2020. Takotsubo cardiomyopathy and COVID-19 infection.
32997792 2020. Superinfections in patients treated with Teicoplanin as anti-SARSCoV2 agent.
32954492 2020. The role of methylprednisolone on preventing disease progression for hospitalized patients with severe COVID-19.
33015820 2020. The therapeutic potential of targeting ACE2 in COVID-19.
33015819 2020. Remdesivir-COVID-19: drug interactions in dentistry.
33015818 2020. Vitamin deficiency as risk factor for SARS-CoV-2 infection: correlation with susceptibility and prognosis.
32965013 2020. A contemporary look at COVID-19 medications: available and potentially effective drugs.
32965012 2020. Nutraceuticals as immune-stimulating therapy to fight COVID-19. Combination of elements to improve the efficacy.
32965010 2020. SARS-CoV-2 infection: NLRP3 inflammasome as plausible target to prevent cardiopulmonary complications?
32894567 2020. Lopinavir/ritonavir for the treatment of SARS, MERS and COVID-19: a systematic review.
32894566 2020. Prospects for the use of regulators of oxidative stress in the comprehensive treatment of the novel Coronavirus Disease 2019 (COVID-19) and its complications.
32971536 2020. Arrhythmic safety of hydroxychloroquine in COVID-19 patients from different clinical settings.
32896184 2020. Remdesivir, a remedy or a ripple in severe COVID-19?
32941780 2020. Therapeutic antibodies and fusion inhibitors targeting the spike protein of SARS-CoV-2.
32941741 2020. Clinical evaluation of Shufeng Jiedu Capsules combined with umifenovir (Arbidol) in the treatment of common-type COVID-19: a retrospective study.
33026628 2020. Autopsy findings in COVID-19-related deaths: a literature review.
32985653 2020. The iminosugars celgosivir, castanospermine and UV-4 inhibit SARS-CoV-2 replication.
32991235 2020. BCG vaccine: a hope to control COVID-19 pandemic amid crisis.
32962524 2020. COVID-19: benefits and risks of passive immunotherapeutics.
32931361 2020. Prospects for mucosal vaccine: shutting the door on SARS-CoV-2.
33024459 2020. Outlook of IL-6 signaling blockade for COVID-19 pneumonia.
33012103 2020. Vitamin D and COVID-19: It is time to act.
32988821 2020. Captisol and GS-704277, but not GS-441524, are credible mediators of remdesivir's nephrotoxicity.
32967849 2020. Favipiravir and the Need for Early Ambulatory Treatment of SARS-CoV2 Infection (COVID-19).
32950264 2020. Coronavirus Disease (COVID-19): Current Status and Prospects for Drug and Vaccine Development.
32929761 2020. Cytokine adsorption in a patient with severe coronavirus disease 2019 related acute respiratory distress syndrome requiring extracorporeal membrane oxygenation therapy: A case report.
32931136 2020. COVID-19 clinical trials: Ethical and scientific consequences of the RECOVERY trial results.
32980462 2020. Evolutionary artificial intelligence based peptide discoveries for effective Covid-19 therapeutics.
32902869 2020. Repurposing Vaccines in the Fight against COVID-19.
33007557 2020. Druggable targets from coronaviruses for designing new antiviral drugs.
32980515 2020. Identification of a novel orally bioavailable NLRP3 inflammasome inhibitor.
32940192 2020. Probiotics against viruses; COVID-19 is a paper tiger: A Systematic Review.
32914732 2020. Oxytocin as a Potential Adjuvant against COVID-19 Infection.
32918829 2020. QTc evaluation in COVID-19 patients treated with chloroquine/hydroxychloroquine: A letter to the editor.
33022271 2020. Can selective serotonin reuptake inhibitors have a neuroprotective effect during COVID-19?
32931783 2020. Curcumin, a traditional spice component, can hold the promise against COVID-19?
33023332 2020. Attenuation of acute and chronic inflammation using compounds derived from plants.
32911560 2020. COVID-19 and Sodium-Glucose Cotransporter 2 Inhibitors: No Fear to Attempt?
33019838 2020. Nano Antiviral Photodynamic Therapy: a Probable Biophysicochemical Management Modality in SARS-CoV-2.
32915657 2020. Are open-source approaches the most efficient way forward for COVID-19 drug discovery?
32915656 2020. Metallo therapeutics for COVID-19. Exploiting metal-based compounds for the discovery of new antiviral drugs.
32981388 2020. Use of hydroxychloroquine for pre-exposure prophylaxis in COVID 19: debate and suggested future course.
32924650 2020. The effect of antivirals on COVID-19: a systematic review.
32903131 2020. Systematic review of the antiviral properties of TRIM56: a potential therapeutic intervention for COVID-19.
32893686 2020. Melatonin as a putative protection against myocardial injury in COVID-19 infection.
33008280 2020. Combining hydroxychloroquine and minocycline: potential role in moderate to severe COVID-19 infection.
32909843 2020. Remdesivir emergency approvals: a comparison of the U.S., Japanese, and EU systems.
32962468 2020. Exploit T cell Immunity for Rapid, Safe and Effective COVID-19 Vaccines.
32940090 2020. Potential effects of vaccinations on the prevention of COVID-19: rationale, clinical evidence, risks, and public health considerations.
32979398 2020. SARS-CoV-2 pathophysiology and its clinical implications: An integrative overview of the pharmacotherapeutic management of COVID-19.
32966484 2020. Inhibitory activities of marine sulfated polysaccharides against SARS-CoV-2.
33011993 2020. Antiviral therapies: advances and perspectives.
32932537 2020. Mercurius solubilis as Genus Epidemicus for the COVID-19 Pandemic.
32942311 2020. Are Adequate Vitamin D Levels Helpful in Fighting COVID-19? A Look at the Evidence.
32993453 2020. COVID-19 vaccine development during pandemic: gap analysis, opportunities, and impact on future emerging infectious disease development strategies.
32991231 2020. Neutralizing antibody response elicited by SARS-CoV-2 receptor-binding domain.
32991223 2020. Considerations on the clinical development of COVID-19 vaccine from trial design perspectives.
32936732 2020. Leveraging on the genomics and immunopathology of SARS-CoV-2 for vaccines development: prospects and challenges.
32961082 2020. Perspectives on development of vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
32951151 2020. Factors Associated with Good Patient Outcomes Following Convalescent Plasma in COVID-19: A Prospective Phase II Clinical Trial.
32936438 2020. Steroids and COVID-19: We Need a Precision Approach, Not One Size Fits All.
32957905 2020. Immuno-Informatics Quest against COVID-19/SARS-COV-2: Determining Putative T-Cell Epitopes for Vaccine Prediction.
32914928 2020. Interim analysis of an open-label randomized controlled trial evaluating nasal irrigations in non-hospitalized patients with coronavirus disease 2019.
32960104 2020. Cautions and Opportunities for Botanicals in COVID-19 Patients: A Comment on the Position of the French Agency for Food, Environmental and Occupational Health & Safety.
32963091 2020. Extracorporeal Treatment for Chloroquine, Hydroxychloroquine, and Quinine Poisoning: Systematic Review and Recommendations from the EXTRIP Workgroup.
32924964 2020. An evidence-based systematic review on emerging therapeutic and preventive strategies to treat novel coronavirus (SARS-CoV-2) during an outbreak scenario.

32958718 2020. A prospective, randomized, open-label trial of early versus late favipiravir in hospitalized patients with COVID-19.
33003552 2020. Oxidative Stress and Inflammation in COVID-19-Associated Sepsis: The Potential Role of Anti-Oxidant Therapy in Avoiding Disease Progression.
32992843 2020. Sex and SP-A2 Dependent NAD(H) Redox Alterations in Mouse Alveolar Macrophages in Response to Ozone Exposure: Potential Implications for COVID-19.
32992775 2020. Glutathione Supplementation as an Adjunctive Therapy in COVID-19.
32967329 2020. Implications of Oxidative Stress and Potential Role of Mitochondrial Dysfunction in COVID-19: Therapeutic Effects of Vitamin D.
32967165 2020. Oxidative Stress, Proton Fluxes, and Chloroquine/Hydroxychloroquine Treatment for COVID-19.
32947974 2020. Phototherapy as a Rational Antioxidant Treatment Modality in COVID-19 Management; New Concept and Strategic Approach: Critical Review.
32972196 2020. Clinical evidences on the antiviral properties of macrolide antibiotics in the COVID-19 era and beyond.
32910955 2020. Structural-based virtual screening and in vitro assays for small molecules inhibiting the feline coronavirus 3CL protease as a surrogate platform for coronaviruses.
32896566 2020. Evaluation of SARS-CoV-2 3C-like protease inhibitors using self-assembled monolayer desorption ionization mass spectrometry.
33015361 2020. Engineering photonics solutions for COVID-19.
32981754 2020. Bioactive Lipids in COVID-19-Further Evidence.
32962867 2020. Targeting SARS-CoV-2 Main Protease: A Computational Drug Repurposing Study.
32905011 2020. SARS-CoV-2 vaccine research and development: conventional vaccines and biomimetic nanotechnology strategies.
32916441 2020. Fight COVID-19 depression with immunity booster: Curcumin for psychoneuroimmunomodulation.
32988654 2020. Recomendaciones para la prevencion de la desnutricion en pacientes con enfermedad del coronavirus 2019 en seguimiento por atencion primaria: Papel del Control Nutricional.
32901559 2020. In search of a vaccine against COVID-19: implications for nursing practice.
32809882 2020. Lopinavir-Ritonavir Treatment for COVID-19 Infection in Intensive Care Unit: Risk of Bradycardia.
32847819 2020. Cytokine storm release syndrome and the prospects for immunotherapy with COVID-19, part 4: The role of JAK inhibition.
32819962 2020. Steroids in COVID-19: An overview.
32936689 2020. Targeted, Site-Specific, Delivery Vehicles of Therapeutics for COVID-19 Patients. Brief Review.
32901809 2020. The Emergence of Baricitinib: A Story of Tortoises Versus Hares.
32818962 2020. Evaluating the Efficacy of Therapies in COVID-19 Patients.
32797239 2020. Baricitinib as treatment for COVID-19: friend or foe of the pancreas?
32797237 2020. Baricitinib: Impact on COVID-19 coagulopathy?
32797235 2020. Response to Correspondence: Baricitinib as Treatment of COVID-19 Friend or Foe of the Pancreas? Cerda-Contreras et.al.
32797226 2020. Response to Correspondence: Baricitinib - Impact on COVID-19 Coagulopathy? Jorgensen et. al.
32785710 2020. Methylprednisolone as Adjunctive Therapy for Patients Hospitalized With COVID-19 (Metcovid): A Randomised, Double-Blind, Phase IIb, Placebo-Controlled Trial.
32952047 2020. Tocilizumab for COVID-19 Pneumonia in a Patient With Non-Small-cell Lung Cancer Treated With Chemoimmunotherapy.
32919071 2020. Impact of convalescent and nonimmune plasma on mortality of patients with COVID-19: a potential role for antithrombin.
33007479 2020. What is the optimal usage of coronavirus disease 2019 convalescent plasma donations?
33007478 2020. Low-to-moderate dose corticosteroids treatment in hospitalized adults with COVID-19.
33007475 2020. Tocilizumab versus the COVID-19 tempest: all's well that ends well or much ado about nothing?
33007474 2020. 'Impact of convalescent and non-immune plasma on mortality of patients with COVID-19: a potential role for antithrombin': authors' response.
32922095 2020. Reduced Prescription of Baloxavir After Suspected Prevalence of a Baloxavir-Resistant Influenza Virus Strain and the Emergence of SARS-CoV-2 in a Tertiary Hospital in Japan.
32904117 2020. Hydroxychloroquine in COVID-19: The Study Points to Premature Decisions on Efficacy While Bells Ringing for Safety.
32990986 2020. COVID-19: A Catalyst to Accelerate Global Regulatory Transformation.
32978778 2020. PharmGKB Tutorial for Pharmacogenomics of Drugs Potentially Used in the Context of COVID-19.
32956575 2020. The Weight of Evidence From Electrophysiology, Observational, and Cardiovascular End Point Studies Demonstrates the Safety of Azithromycin.
32955785 2020. Risk of Metformin in Patients With Type 2 Diabetes With COVID-19: A Preliminary Retrospective Report.
32932348 2020. Guiding Principles for the Conduct of Observational Critical Care Research for Coronavirus Disease 2019 Pandemics and Beyond: The Society of Critical Care Medicine Discovery Viral Infection and Respiratory Illness Universal Study Registry.
32984987 2020. Superiority of cilostazol among antiplatelet FDA-approved drugs against COVID 19 M(pro) and spike protein: Drug repurposing approach.
32944968 2020. Cholesterol 25-Hydroxylase inhibits SARS-CoV-2 and other coronaviruses by depleting membrane cholesterol.
33026460 2020. The ten reasons why corticosteroid therapy reduces mortality in severe COVID-19.
32912355 2020. Vitamin D deficiency in schizophrenia implications for COVID-19 infection.
32804015 2020. A novel biparatopic hybrid antibody-ACE2 fusion that blocks SARS-CoV-2 infection: implications for therapy.
33012364 2020. Exclusion of Older Adults in COVID-19 Clinical Trials.
33016032 2020. Is androgen deprivation therapy protective against SARS-CoV-2 infection and related complications in prostate cancer patients?
32991794 2020. Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older Adults.
32876154 2020. Reasons to avoid vitamin D deficiency during COVID-19 pandemic.
33009120 2020. A Potential Antiviral Treatment for COVID-19: Remdesivir.
33009111 2020. A Potential Antiviral Treatment for COVID-19: Remdesivir.
32896174 2020. Response to Comment on "Truncated IV acetylcysteine treatment duration has potential to safely preserve resources during the COVID-19 pandemic".
32960100 2020. Toxicity of chloroquine and hydroxychloroquine following therapeutic use or overdose.
32970917 2020. Enabling Warp Speed Using the Hypervelocity Innovation Model: A Blue Print for Drug Development in Pandemics.
32936528 2020. Important Pharmacogenetic Information for Drugs Prescribed During the SARS-CoV-2 Infection (COVID-19).
32926573 2020. Effect of Combination Therapy of Hydroxychloroquine and Azithromycin on Mortality in Patients With COVID-19.
32918792 2020. Tocilizumab as a Therapeutic Agent for Critically Ill Patients Infected with SARS-CoV-2.
32964653 2020. Insights on the evidence of cardiotoxicity of hydroxychloroquine prior and during COVID-19 epidemic.
32940925 2020. Heart transplant recipients with confirmed 2019 novel coronavirus infection: The Detroit experience.
32918761 2020. Treatment with convalescent plasma in solid organ transplant recipients with COVID-19: Experience at large transplant center in New York City.
32928086 2020. In silico modeling of small molecule carboxamides as inhibitors of SARS-CoV 3CL protease: An approach towards combating COVID-19.
33001008 2020. Analysis of Chinese herbal formulae recommended for COVID-19 in different schemes in China: A data mining Approach.
32891290 2020. A narrative literature review on traditional medicine options for treatment of corona virus disease 2019 (COVID-19).
32911432 2020. Site mapping and small molecule blind docking reveal a possible target site on the SARS-CoV-2 main protease dimer interface.
32961361 2020. Data monitoring committees for clinical trials evaluating treatments of COVID-19.
32964827 2020. Design and in-silico screening of Peptide Nucleic Acid (PNA) inspired novel pronucleotide scaffolds targeting COVID-19.
32940180 2020. The Use of cyclodextrin or its complexes as a potential treatment against the 2019 novel coronavirus. A mini-review.
32938349 2020. Role of novel drug delivery systems in coronavirus disease-2019 (covid-19): time to act now.
32957889 2020. Identification of Main Protease of Coronavirus SARS-CoV-2 (Mpro)Inhibitors from Melissa officinalis.
32972339 2020. Targeting host cell proteases to prevent SARS-CoV-2 invasion.
32900341 2020. Current scenario and future prospect in the management of COVID-19.
33019921 2020. Potential repurposing of drugs with anti-SARS-CoV-2 activity in preclinical trials: a systematic review.
32957884 2020. Quercetin and its relative therapeutic potential against COVID-19: A retrospective review and prospective overview.
33003119 2020. A brief discussion of the benefit and mechanism of vitamin D supplementation on coronavirus disease 2019.
32969973 2020. Coronavirus disease-19 vaccine development utilizing promising technology.
33003993 2020. Therapeutic Options and Treatment Strategies Against COVID-19 in China.
33001004 2020. Potential Therapeutic Benefits of Dipyridamole in COVID-19 Patients.
32954998 2020. Emergence of human pathogenic Coronaviruses: Lectins as antivirals for SARS-CoV-2.
32901582 2020. Fusion protein targeted antiviral peptides: fragment based drug design (FBDD) guided rational design of dipeptides against SARS-CoV-2.
32957901 2020. Drug Repurposing Approaches: Existing Leads For Novel Threats And Drug Targets.
32951577 2020. Carbohydrate-Binding Agents: Potential of Repurposing for COVID-19 Therapy.
32962613 2020. Progress in Studies on Structural and Remedial Aspects of Newly Born Coronavirus, SARS-CoV-2.
33009266 2020. Tracking a Vaccine and Developing Therapeutics for COVID-19.
32966232 2020. Understanding COVID-19 in the light of epidemic disease described in Unani medicine.
32914465 2020. Why nobody discusses the adverse psychiatric effects of chloroquine in case it might become the future treatment against COVID-19?
32931359 2020. Radiotherapy in the fight against pneumonia associated with SARS-CoV-2.
32910699 2020. A combinatorial approach of a polypharmacological adjuvant 2-deoxy-D-glucose with low dose radiation therapy to quell the cytokine storm in COVID-19 management.
32909697 2020. Targeting SARS CoV2 (Indian isolate) genome with miRNA: An in silico study.
32568274 2020. Hydroxychloroquine and coronavirus disease 2019.
32842905 2020. Physical activity and nutrition guidelines to help with the fight against COVID-19.
32940656 2020. In Vitro Efficacy of a Povidone-Iodine Nasal Antiseptic for Rapid Inactivation of SARS-CoV-2.
32861315 2020. COVID-19 vaccine trials should seek worthwhile efficacy.
32896293 2020. Azithromycin for severe COVID-19.
32896292 2020. Azithromycin in addition to standard of care versus standard of care alone in the treatment of patients admitted to the hospital with severe COVID-19 in Brazil (COALITION II): a randomised clinical trial.
32795409 2020. Inclusion of pregnant women in COVID-19 vaccine development.
32896275 2020. COVID-19 vaccine trials in Africa.
32896274 2020. The Russian vaccine for COVID-19.
32734625 2020. BCG vaccination early in life does not improve COVID-19 outcome of elderly populations, based on nationally reported data.
32902339 2020. Efficacy and safety of ruxolitinib for Covid-19 related acute respiratory distress syndrome in a patient with blastic plasmacytoid dendritic cell neoplasm (leukemic variant).
32519613 2020. Hydroxychloroquine and coronavirus disease 19.
32783352 2020. Antiviral Activity of Nanomaterials against Coronaviruses.
32972631 2020. Point of view: Should COVID-19 patients be supplemented with vitamin D?
32767936 2020. Possible Targets and Therapies of SARS-CoV-2 Infection.
32838716 2020. Drug Discovery by Drug Repurposing: Combating COVID-19 in the 21st Century.
32844821 2020. Systematic Review on Repurposing Use of Favipiravir Against SARS-CoV-2.
32897660 2020. "When Will We Have a Vaccine?" - Understanding Questions and Answers about Covid-19 Vaccination.
32813942 2020. A SARS-CoV-2 mRNA Vaccine - Preliminary Report. Reply.
32813941 2020. A SARS-CoV-2 mRNA Vaccine - Preliminary Report.
32813940 2020. A SARS-CoV-2 mRNA Vaccine - Preliminary Report.
32905696 2020. Audio Interview: Guidelines for Covid-19 Vaccine Deployment.
32966716 2020. Evaluating and Deploying Covid-19 Vaccines - The Importance of Transparency, Scientific Integrity, and Public Trust.

32816219 2020. Use of Azithromycin in COVID-19: A Cautionary Tale.
32951190 2020. Could Tocilizumab be an Attractive Therapeutic Option for Elderly Patients with Severe COVID-19? A Case Report.
32838064 2020. Remdesivir and its antiviral activity against COVID-19: A systematic review.
32813879 2020. Factors determining COVID-19 pneumonia severity in a country with routine BCG vaccination.
32202241 2020. Therapies used in rheumatology with relevance to coronavirus disease 2019.
32864377 2020. Is the impact of childhood vaccines on coronavirus disease 2019, which is moderate in pediatric patients, possible?
32864376 2020. Current national policies for infant universal bacille Calmette-Guerin vaccination were associated with lower mortality from coronavirus disease 2019.
32864373 2020. An edible vaccine development for coronavirus disease 2019: the concept.
33010411 2020. Digestive Manifestations in Patients Hospitalized with COVID-19.
32961333 2020. Complement C3 vs C5 inhibition in severe COVID-19: Early clinical findings reveal differential biological efficacy.
32426812 2020. Reduction of coronavirus burden with mass azithromycin distribution.
33007473 2020. Re: Effect of hydroxychloroquine with or without azithromycin on the mortality of COVID-19 patients' by Fiolet et al.
32987193 2020. Re: 'Effect of hydroxychloroquine with or without azithromycin on the mortality of COVID-19 patients' by Fiolet et al.
32979572 2020. Effects of tocilizumab on mortality in hospitalized patients with COVID-19: a multicentre cohort study.
32971254 2020. Efficacy of corticosteroid treatment for hospitalized patients with severe COVID-19: a multicentre study.
32791241 2020. Treatment of COVID-19 with convalescent plasma: lessons from past coronavirus outbreaks.
32860964 2020. Treatment with tocilizumab or corticosteroids for COVID-19 patients with hyperinflammatory state: a multicentre cohort study (SAM-COVID-19).
32860962 2020. Effect of hydroxychloroquine with or without azithromycin on the mortality of coronavirus disease 2019 (COVID-19) patients: a systematic review and meta-analysis.
32792417 2020. Convalescent Plasma Therapy for COVID-19: State of the Art.
32922210 2020. Hydroxychloroquine and dexamethasone in COVID-19: who won and who lost?
32900518 2020. Malnutrition and nutritional therapy in patients with SARS-CoV-2 disease.
32917563 2020. Convalescent fecal microbiota transplantation as a possible treatment for COVID-19.
32905148 2020. Convalescent Plasma Therapy and Its Effects On COVID-19 Patient Outcomes: A Systematic Review of Current Literature.
32983702 2020. A Meta-Analysis on the Effects of Hydroxychloroquine on COVID-19.
32839724 2020. Timelines of COVID-19 vaccines.
33015428 2020. Biosurfactants and anti-inflammatory activity: A potential new approach towards COVID-19.
32923374 2020. Potential use of polyphenols in the battle against COVID-19.
32938545 2020. AntagomiRs: A novel therapeutic strategy for challenging COVID-19 cytokine storm.
32948440 2020. Glycogen synthase kinase-3: A putative target to combat severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic.
32895645 2020. Tocilizumab for severe COVID-19 related illness - A community academic medical center experience.
32905939 2020. No benefit of hydroxychloroquine in COVID-19: Results of Systematic Review and Meta-Analysis of Randomized Controlled Trials".
32927405 2020. Balanced nutrition is needed in times of COVID19 epidemic in India: A call for action for all nutritionists and physicians.
32943897 2020. Beneficial Effects of Anti-Oxidative Herbal Medicines in Diabetic Patients Infected with COVID-19: A Hypothesis.
32949651 2020. Hyperglycemia, glucocorticoid therapy, and outcome of COVID-19.
32946854 2020. Use of DPP4 inhibitors in Italy does not correlate with diabetes prevalence among COVID-19 deaths.
32926957 2020. Inpatient use of glucocorticoids may mediate the detrimental effect of new-onset hyperglycemia on COVID-19 severity.
32922517 2020. Dexamethasone in the era of COVID-19: friend or foe? An essay on the effects of dexamethasone and the potential risks of its inadvertent use in patients with diabetes.
33013251 2020. Immunomodulation Through Low-Dose Radiation for Severe COVID-19: Lessons From the Past and New Developments.
32908842 2020. Hydroxychloroquine in a G6PD-Deficient Patient with COVID-19 Complicated by Haemolytic Anaemia: Culprit or Innocent Bystander?
33011825 2020. Quality of adverse event reporting in clinical trials of remdesivir in patients with COVID-19.
32817221 2020. Broad Anti-coronavirus Activity of Food and Drug Administration-Approved Drugs against SARS-CoV-2 In Vitro and SARS-CoV In Vivo.
33001138 2020. Efficacy and Safety of Hydroxychloroquine vs Placebo for Pre-exposure SARS-CoV-2 Prophylaxis Among Health Care Workers: A Randomized Clinical Trial.
33012348 2020. SARS-CoV-2 Vaccine Development: Current Status.
33017914 2020. Alpha-lipoic acid may protect patients with diabetes against COVID-19 infection.
33017913 2020. Can neuromodulation support the fight against the COVID19 pandemic? Transcutaneous non-invasive vagal nerve stimulation as a potential targeted treatment of fulminant acute respiratory distress syndrome.
33017912 2020. A new approach for COVID-19 treatment by micro-RNA.
33017910 2020. Defensin 5 for prevention of SARS-CoV-2 invasion and Covid-19 disease.
33017909 2020. Could aquaporin modulators be employed as prospective drugs for COVID-19 related pulmonary comorbidity?
33017907 2020. Infection-iron interaction during COVID-19 pandemic: Time to re-design iron supplementation programs.
33017906 2020. Exercise as medicine for COVID-19: On PPAR with emerging pharmacotherapy.
33017904 2020. Inhaled hydroxychloroquine to improve efficacy and reduce harm in the treatment of COVID-19.
33022293 2020. Clinical trial protocols of repurposed prophylaxis for COVID-19: a review.
33027420 2020. COVID-19: molecular targets, drug repurposing and new avenues for drug discovery.
33027419 2020. Flavonoid glycosides and their putative human metabolites as potential inhibitors of the SARS-CoV-2 main protease (Mpro) and RNA-dependent RNA polymerase (RdRp).
33016666 2020. Quercetin Phytosome(R) as a potential candidate for managing COVID-19.
33009401 2020. SARS-CoV2-mediated suppression of NRF2-signaling reveals potent antiviral and anti-inflammatory activity of 4-octyl-itaconate and dimethyl fumarate.
33025261 2020. A Systems Biology Workflow for Drug and Vaccine Repurposing: Identifying Small-Molecule BCG Mimics to Reduce or Prevent COVID-19 Mortality.
33023033 2020. COVID-19: Current Developments and Further Opportunities in Drug Delivery and Therapeutics.
32978861 2020. Preparing for COVID-19 vaccine safety surveillance: A United States perspective.
33006138 2020. Acetylcysteine for the Treatment of Suspected Remdesivir-Associated Acute Liver Failure in COVID-19: A Case Series.
33006163 2020. Coagulopathy, Venous Thromboembolism, and Anticoagulation in Patients with COVID-19.
33024017 2020. Decoy nanoparticles protect against COVID-19 by concurrently adsorbing viruses and inflammatory cytokines.
32936918 2020. COVID-19 & Hydroxychloroquine side-effects: Glucose 6-phosphate dehydrogenase deficiency (G6PD) and acute haemolytic anaemia.
32942307 2020. Can Glycine Mitigate COVID-19 Associated Tissue Damage and Cytokine Storm?
32954552 2020. Severe COVID-19 and interleukin-6 receptor antagonist tocilizumab: Some notes of concern.
33027439 2020. Should ethanol be considered a treatment for COVID-19?
32969125 2020. Azithromycin in viral infections.
32965078 2020. Severe acute respiratory syndrome-coronavirus-2: Current advances in therapeutic targets and drug development.
32897326 2020. Drug Repurposing Study Pinpoints Potential COVID-19 Antivirals.
32789505 2020. Effect of an Inactivated Vaccine Against SARS-CoV-2 on Safety and Immunogenicity Outcomes: Interim Analysis of 2 Randomized Clinical Trials.
32789500 2020. An Inactivated Virus Candidate Vaccine to Prevent COVID-19.
32880613 2020. COVID-19 and mRNA Vaccines-First Large Test for a New Approach.
32930767 2020. Interest in Global COVID-19 Vaccine Alliance Grows.
32821939 2020. Effect of Remdesivir vs Standard Care on Clinical Status at 11 Days in Patients With Moderate COVID-19: A Randomized Clinical Trial.
32821934 2020. Efficacy of Remdesivir in COVID-19.
32808972 2020. Ethical Considerations for COVID-19 Vaccine Trials in Correctional Facilities.
32910182 2020. Fairly Prioritizing Groups for Access to COVID-19 Vaccines.
32789501 2020. Researchers Strive to Recruit Hard-Hit Minorities Into COVID-19 Vaccine Trials.
32915201 2020. COVID-19 and the Path to Immunity.
32910154 2020. Reassuring the Public and Clinical Community About the Scientific Review and Approval of a COVID-19 Vaccine.
32876697 2020. Effect of Hydrocortisone on Mortality and Organ Support in Patients With Severe COVID-19: The REMAP-CAP COVID-19 Corticosteroid Domain Randomized Clinical Trial.
32876695 2020. Effect of Dexamethasone on Days Alive and Ventilator-Free in Patients With Moderate or Severe Acute Respiratory Distress Syndrome and COVID-19: The CoDEX Randomized Clinical Trial.
32876694 2020. Association Between Administration of Systemic Corticosteroids and Mortality Among Critically Ill Patients With COVID-19: A Meta-analysis.
32876693 2020. Corticosteroids in COVID-19 ARDS: Evidence and Hope During the Pandemic.
32876689 2020. Effect of Hydrocortisone on 21-Day Mortality or Respiratory Support Among Critically Ill Patients With COVID-19: A Randomized Clinical Trial.
32870268 2020. Regulatory Decision-making on COVID-19 Vaccines During a Public Health Emergency.
32496545 2020. Challenge Trials-Could Deliberate Coronavirus Exposure Hasten Vaccine Development?
32936268 2020. Myocardial Injury in COVID-19-Can We Successfully Target Inflammation?-Reply.
32936267 2020. Myocardial Injury in COVID-19-Can We Successfully Target Inflammation?
32936260 2020. Understanding Observational Treatment Comparisons in the Setting of Coronavirus Disease 2019 (COVID-19).
32936259 2020. Hydroxychloroquine, Coronavirus Disease 2019, and QT Prolongation.
32986099 2020. The Exclusion of Older Persons From Vaccine and Treatment Trials for Coronavirus Disease 2019-Missing the Target.
32910179 2020. Effect of Recombinant Human Granulocyte Colony-Stimulating Factor for Patients With Coronavirus Disease 2019 (COVID-19) and Lymphopenia: A Randomized Clinical Trial.
32910155 2020. Immune Stimulation With Recombinant Human Granulocyte Colony-Stimulating Factor for Coronavirus Disease 2019 (COVID-19)-Beware of Blind Spots.
32804187 2020. Policy Implications of the Orphan Drug Designation for Remdesivir to Treat COVID-19.
32930097 2020. Protective potential of expectorants against COVID-19.
32854988 2020. Tratamiento farmacologico de la COVID-19: revision narrativa de los Grupos de Trabajo de Enfermedades Infecciosas y Sepsis (GTEIS) y del Grupo de Trabajo de Transfusiones Hemoderivados (GTTH).
32864815 2020. COVID-19 drug repurposing: A review of computational screening methods, clinical trials, and protein interaction assays.
33003134 2020. Effect of sex hormones on coronavirus disease 2019: an analysis of 5,061 laboratory-confirmed cases in South Korea.
32883053 2020. Probiotics in COVID-19 pandemic: when evidence lacks, rationale can still ease the way.
32780573 2020. Racial Disproportionality in Covid Clinical Trials.
32641838 2020. Coronavirus vaccine developers wary of errant antibodies.
32358594 2020. Convalescent serum lines up as first-choice treatment for coronavirus.
32205870 2020. Coronavirus puts drug repurposing on the fast track.
32884153 2020. Ad26 vaccine protects against SARS-CoV-2 severe clinical disease in hamsters.
33017102 2020. Is vitamin D deficiency a risk factor for COVID-19 in children?
32893957 2020. The promise and pitfalls of composite endpoints in sepsis and COVID-19 clinical trials.
32936069 2020. Biophotonics in Health Care and Its Relevance in Fighting the Coronavirus Disease.
32946328 2020. Transcatheter Endoluminal Phototherapy as a Possible Adjunct Treatment for Patients with COVID-19.
33008960 2020. Review on therapeutic targets for COVID-19: insights from cytokine storm.
32962623 2020. The Role of Tocilizumab in Cytokine Storm and Improving Outcomes in COVID-19.
32962996 2020. A treatment that eliminates SARS-CoV-2 replication in human airway epithelial cells and is safe for inhalation as an aerosol in healthy human subjects.

33012890 2020. Drug Repositioning for COVID-19.
32979815 2020. Identification of novel human USP2 inhibitor and its putative role in treatment of COVID-19 by inhibiting SARS-CoV-2 papain-like (PLpro) protease.
32913581 2020. Unlocking COVID therapeutic targets: A structure-based rationale against SARS-CoV-2, SARS-CoV and MERS-CoV Spike.
32927092 2020. Selecting appropriate endpoints for assessing treatment effects in comparative clinical studies for COVID-19.
32894156 2020. Plasma exchange in critically ill COVID-19 patients improved inflammation, microcirculatory clot formation, and hypotension, thereby improving clinical outcomes: fact or fiction?
32993751 2020. Efficacy of tocilizumab in patients with COVID-19 ARDS undergoing noninvasive ventilation.
32977854 2020. Oral favipiravir for patients with delayed SARS-CoV-2 viral RNA clearance: a case series.
32972429 2020. Fibrin-derived peptide Bbeta15-42 (FX06) as salvage treatment in critically ill patients with COVID-19-associated acute respiratory distress syndrome.
32958060 2020. Glucocorticoid therapy does not delay viral clearance in COVID-19 patients.
32984840 2020. Treatment of Critically Ill Coronavirus Disease 2019 Patients With Adjunct Therapeutic Plasma Exchange: A Single-Center Retrospective Case Series.
32984833 2020. Placenta-Derived Cell Therapy to Treat Patients With Respiratory Failure Due to Coronavirus Disease 2019.
32983745 2020. Micronutrients in COVID-19 Positive Pregnancies.
32963923 2020. In Vitro Virucidal Effect of Intranasally Delivered Chlorpheniramine Maleate Compound Against Severe Acute Respiratory Syndrome Coronavirus 2.
32953365 2020. Therapeutic Options for COVID-19: A Review.
33025718 2020. Investigator initiated research in times of COVID-19: Let's go digital!
32959499 2020. Response to Letter to the Editor Regarding: "The Use of Non-Invasive Vagus Nerve Stimulation to Treat Respiratory Symptoms Associated With COVID-19: A Theoretical Hypothesis and Early Clinical Experience".
32945085 2020. Nutrition management for critically and acutely unwell hospitalised patients with coronavirus disease 2019 (COVID-19) in Australia and New Zealand.
32974671 2020. The implications of vitamin D deficiency on COVID-19 for at-risk populations.
32963376 2020. COVID-19 clinical trials: learning from exceptions in the research chaos.
32934372 2020. Convalescent plasma treatment of severe COVID-19: a propensity score-matched control study.
32913338 2020. Developing COVID-19 vaccines.
32839620 2020. Vaccines targeting SARS-CoV-2 tested in humans.
32699874 2020. Rocaglamide and silvestrol: a long story from anti-tumor to anti-coronavirus compounds.
32787584 2020. Rapid determination and optimisation of berberine from Himalayan Berberis lycium by soxhlet apparatus using CCD-RSM and its quality control as a potential candidate for COVID-19.
32887942 2020. Evolution of the COVID-19 vaccine development landscape.
32788747 2020. The impact of COVID-19 on kidney transplantation.
32908295 2020. A leading coronavirus vaccine trial is on hold: scientists react.
32948865 2020. Who gets a COVID vaccine first? Access plans are taking shape.
32934375 2020. Researchers highlight 'questionable' data in Russian coronavirus vaccine trial results.
32929259 2020. Scientists relieved as coronavirus vaccine trial restarts - but question lack of transparency.
32908297 2020. The underdog coronavirus vaccines that the world will need if front runners stumble.
32811981 2020. What the immune response to the coronavirus says about the prospects for a vaccine.
32998157 2020. COVID-19 vaccine BNT162b1 elicits human antibody and TH1 T cell responses.
32994572 2020. COVID vaccine confidence requires radical transparency.
32978611 2020. COVID-vaccine results are on the way - and scientists' concerns are growing.
32967006 2020. SARS-CoV-2 vaccines in development.
32940950 2020. Effects of Exercise on ACE2.